Humana Inc. (HUM)
Louisville, KY, US
Humana Inc., a prominent health and well-being enterprise, operates across the United States through its various subsidiary companies. Its operational structure is divided into three main segments: Retail, Group and Specialty, and Healthcare Services. The firm provides a wide array of medical and supplementary insurance plans directly to individual consumers. Furthermore, Humana collaborates with government entities; it holds a contract with the Centers for Medicare and Medicaid Services (CMS) to manage the Limited Income Newly Eligible Transition (LI NET) prescription drug program. The company also secures agreements with numerous states to deliver Medicaid, dual-eligible, and long-term care support benefits. For employer groups and individuals, Humana furnishes fully insured commercial medical and specialized health coverage, which encompasses dental, vision, and other ancillary health benefits. They additionally offer administrative services only (ASO) solutions and extend support to military personnel through contracts like the TRICARE T2017 East Region. Beyond insurance products, the company delivers comprehensive healthcare services directly. These include pharmacy management, provider network services, and a suite of home-based solutions such as home health care, serving both its own health plan enrollees and external clients. By the close of 2021 (December 31), Humana's reach extended to approximately 17 million individuals enrolled in its medical benefit plans and an additional 5 million utilizing its specialized product offerings. Established in 1961, Humana Inc. maintains its corporate headquarters in Louisville, Kentucky.
Based on only 1 article — low confidence
- Humana Eyes 3% Medicare Advantage Margin: Can It Deliver? Zacks Investment Research
No mergers or acquisitions recorded for this company.
Index membership
| Index | Added | Removed | Status |
|---|---|---|---|
| S&P 500 | 1979-02-08 | — | Active |
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.25% | +11.59% | +42.73% | +53.36% | +14.05% | +7.08% | +8.46% | -47.99% | -39.56% | +65.41% | +22,947.06% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 6 | 0 |
| Hold | 16 | -1 |
| Sell | 2 | 0 |
| Strong Sell | 0 | 0 |
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 8 |
247.75
-39.0%
|
| Last Quarter | 18 |
225.83
-44.4%
|
| Last Year | 38 |
256.29
-36.9%
|
| All Time | 89 |
375.61
-7.5%
|
-
Revenue growth Medical - Healthcare Plans: +11.8%+10.1% Q1'26: +23.5% (vs Q1'25)
-
EPS growth Medical - Healthcare Plans: -1.4%-1.4% Q1'26: -4.6% (vs Q1'25)
-
FCF margin FCF growth · Medical - Healthcare Plans: +15.1%-0.2% Q1'26: +2.9% (vs Q1'25)
-
EBIT margin Medical - Healthcare Plans: +3.3%+1.6% Q1'26: +4.5% (vs Q1'25)
-
ROIC Medical - Healthcare Plans: +6.7%+6.5% Q1'26: +49.8% (vs Q1'25)
-
Share dilution Medical - Healthcare Plans: +2.1%0.0% Q1'26: -0.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Healthcare Plans: 0.93×4.45× Q1'26: 1.78× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2011 actual |
Dec 2012 actual |
Dec 2013 actual |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 16 Rev. Ana. 16 EPS Ana. |
Dec 2027 17 Rev. Ana. 15 EPS Ana. |
Dec 2028 14 Rev. Ana. 7 EPS Ana. |
Dec 2029 9 Rev. Ana. 2 EPS Ana. |
Dec 2030 13 Rev. Ana. 5 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
36.83B
est: 32.34B (+13.9%)
|
39.13B
est: 36.74B (+6.5%)
|
41.31B
est: 37.79B (+9.3%)
|
48.50B
est: 47.87B (+1.3%)
|
54.29B
est: 54.26B (+0.1%)
|
54.41B
est: 54.95B (-1.0%)
|
53.80B
est: 53.49B (+0.6%)
|
56.94B
est: 56.59B (+0.6%)
|
64.93B
est: 64.76B (+0.3%)
|
77.19B
est: 76.06B (+1.5%)
|
83.65B
est: 83.07B (+0.7%)
|
92.92B
est: 92.96B (0.0%)
|
106.44B
est: 112.04B (-5.0%)
|
117.81B
est: 117.01B (+0.7%)
|
129.66B
est: 129.18B (+0.4%)
|
162.37B
160.86B – 164.89B
+25.7% YoY
|
170.58B
160.30B – 183.56B
+5.1% YoY
|
181.85B
181.46B – 182.23B
+6.6% YoY
|
194.42B
187.77B – 204.01B
+6.9% YoY
|
207.23B
200.14B – 217.45B
+6.6% YoY
|
| EBITDA |
—
est: 2.13B (-100.0%)
|
46.00M
est: 2.13B (-97.8%)
|
—
est: 1.98B (-100.0%)
|
—
est: 2.72B (-100.0%)
|
-270.00M
est: 3.06B (-108.8%)
|
—
est: 2.16B (-100.0%)
|
-936.00M
est: 4.34B (-121.6%)
|
2.83B
est: 2.66B (+6.4%)
|
4.29B
est: 3.91B (+9.7%)
|
5.57B
est: 4.60B (+21.3%)
|
4.46B
est: 4.23B (+5.3%)
|
4.81B
est: 4.71B (+2.1%)
|
4.73B
est: 4.47B (+5.8%)
|
3.26B
est: 4.67B (-30.3%)
|
2.91B
est: 5.16B (-43.6%)
|
6.48B
6.42B – 6.58B
+25.7% YoY
|
6.81B
6.40B – 7.33B
+5.1% YoY
|
7.26B
7.24B – 7.27B
+6.6% YoY
|
7.76B
7.49B – 8.14B
+6.9% YoY
|
8.27B
7.99B – 8.68B
+6.6% YoY
|
| EBIT |
2.65B
est: 1.34B (+97.7%)
|
2.35B
est: 1.52B (+54.8%)
|
2.49B
est: 1.56B (+59.0%)
|
2.81B
est: 1.98B (+41.9%)
|
3.06B
est: 2.25B (+36.4%)
|
2.21B
est: 2.27B (-3.0%)
|
4.75B
est: 2.21B (+114.4%)
|
2.29B
est: 2.34B (-2.2%)
|
3.71B
est: 2.68B (+38.5%)
|
4.96B
est: 3.15B (+57.4%)
|
3.75B
est: 2.90B (+29.1%)
|
3.97B
est: 3.19B (+24.2%)
|
3.81B
est: 3.56B (+7.2%)
|
2.29B
est: 3.72B (-38.4%)
|
2.08B
est: 4.10B (-49.2%)
|
5.16B
5.11B – 5.24B
+25.7% YoY
|
5.42B
5.09B – 5.83B
+5.1% YoY
|
5.77B
5.76B – 5.79B
+6.6% YoY
|
6.17B
5.96B – 6.48B
+6.9% YoY
|
6.58B
6.35B – 6.90B
+6.6% YoY
|
| Net Income |
1.42B
est: 1.13B (+25.5%)
|
1.22B
est: 1.10B (+10.8%)
|
1.23B
est: 945.87M (+30.1%)
|
1.15B
est: 1.10B (+4.3%)
|
1.28B
est: 1.28B (0.0%)
|
614.00M
est: 582.74M (+5.4%)
|
2.45B
est: 2.23B (+10.0%)
|
1.68B
est: 1.58B (+6.4%)
|
2.71B
est: 2.47B (+9.8%)
|
3.37B
est: 2.75B (+22.4%)
|
2.93B
est: 2.79B (+5.2%)
|
2.81B
est: 2.95B (-4.9%)
|
2.49B
est: 1.71B (+45.5%)
|
1.21B
est: 1.94B (-37.8%)
|
1.19B
est: 2.07B (-42.7%)
|
995.34M
972.92M – 1.17B
-52.0% YoY
|
1.74B
1.52B – 2.17B
+74.5% YoY
|
2.62B
2.49B – 3.58B
+50.7% YoY
|
4.67B
4.46B – 4.97B
+78.3% YoY
|
4.99B
4.76B – 5.30B
+6.8% YoY
|
| SGA |
—
est: 4.58B (-100.0%)
|
—
est: 5.34B (-100.0%)
|
—
est: 5.73B (-100.0%)
|
—
est: 7.53B (-100.0%)
|
—
est: 7.32B (-100.0%)
|
—
est: 7.13B (-100.0%)
|
—
est: 6.10B (-100.0%)
|
—
est: 7.10B (-100.0%)
|
—
est: 6.81B (-100.0%)
|
—
est: 9.05B (-100.0%)
|
—
est: 9.55B (-100.0%)
|
—
est: 6.17B (-100.0%)
|
—
|
—
|
—
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| EPS |
8.58
est: 5.84 (+46.9%)
|
7.57
est: 6.37 (+18.8%)
|
7.82
est: 6.29 (+24.4%)
|
7.44
est: 7.10 (+4.8%)
|
8.54
est: 7.75 (+10.2%)
|
4.11
est: 9.52 (-56.8%)
|
16.94
est: 11.63 (+45.6%)
|
12.24
est: 14.43 (-15.2%)
|
20.19
est: 17.77 (+13.6%)
|
25.47
est: 18.66 (+36.5%)
|
22.79
est: 20.54 (+11.0%)
|
22.20
est: 25.06 (-11.4%)
|
20.09
est: 14.04 (+43.0%)
|
10.01
est: 16.12 (-37.9%)
|
9.87
est: 17.09 (-42.2%)
|
8.94
8.05 – 9.72
-47.7% YoY
|
15.29
12.59 – 17.93
+71.1% YoY
|
25.97
20.59 – 29.67
+69.9% YoY
|
38.62
36.90 – 41.09
+48.7% YoY
|
41.26
39.42 – 43.91
+6.8% YoY
|
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-05-01 | JP Morgan | Neutral | Neutral | Maintain |
| 2026-04-30 | Truist Securities | Hold | Hold | Maintain |
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-08 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-07 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-06 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-05 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-04 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-01 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-30 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-29 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-28 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-27 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-24 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-23 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-22 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-21 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-20 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-17 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-16 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-15 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
Owner Earnings
Ownership Overview
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Bruce R. Berkowitz | 15.88M | 9.40% | — | 14.05M | — | 15.88M | HC, IN | United States of America | 2010-02-16 | ↗ |
| 2 | Fairholme Capital Management, L.L.C. | 15.88M | 9.40% | — | 14.05M | — | 15.88M | IA | Delaware | 2010-02-16 | ↗ |
| 3 | BlackRock for purposes of Schedule 13G filings. | 14.99M | 8.83% | 14.99M | — | 14.99M | — | HC | Delaware | 2010-01-29 | ↗ |
| 4 | Fairholme Funds, Inc. | 12.83M | 7.60% | — | 12.83M | — | 12.83M | IV | Maryland | 2010-02-16 | ↗ |
| 5 | (1) BlackRock, Inc. | 11.25M | 8.80% | 9.81M | — | 11.25M | — | HC | Delaware | 2022-02-01 | ↗ |
| 6 | Humana Inc. | 10.88M | 4.50% | 10.88M | — | 10.88M | — | CO | — | 2022-02-04 | ↗ |
| 7 | 52-0556948 | 10.51M | 8.10% | 3.40M | — | 10.51M | — | IA | Maryland | 2022-02-14 | ↗ |
| 8 | Capital International Investors ** | 10.14M | 7.60% | 10.12M | — | 10.14M | — | IA | California | 2020-02-14 | ↗ |
| 9 | The Vanguard Group - 23-1945930 | 10.01M | 7.79% | — | 203.6K | 9.49M | 519.6K | IA | — | 2022-02-10 | ↗ |
| 10 | FMR LLC | 9.21M | 6.44% | 910.2K | — | 9.21M | — | HC | Delaware | 2018-02-13 | ↗ |
| 11 | Capital Research Global Investors ** | 7.83M | 5.90% | 7.83M | — | 7.83M | — | IA | Delaware | 2020-02-14 | ↗ |
| 12 | 04-2683227 | 7.70M | 4.58% | — | 858.6K | — | — | IA | Massachusetts | 2011-02-14 | ↗ |
| 13 | Wellington Group Holdings LLP | 7.61M | 6.01% | — | 7.18M | — | — | HC | Massachusetts | 2023-02-06 | ↗ |
| 14 | Wellington Investment Advisors Holdings LLP | 7.61M | 6.01% | — | 7.18M | — | — | HC | Massachusetts | 2023-02-06 | ↗ |
| 15 | Wellington Management Group LLP | 7.61M | 6.01% | — | 7.18M | — | — | HC | Massachusetts | 2023-02-06 | ↗ |
| 16 | LAWRENCE M. ROBBINS | 7.49M | 5.05% | — | 7.49M | — | 7.49M | HC, IN | Delaware | 2015-11-27 | ↗ |
| 17 | Wellington Management Company LLP | 6.76M | 5.34% | — | 6.65M | — | — | IA | Massachusetts | 2023-02-06 | ↗ |
| 18 | GLENVIEW CAPITAL MANAGEMENT, LLC | 6.31M | 4.23% | — | 6.31M | — | 6.31M | OO | Delaware | 2017-02-14 | ↗ |
| 19 | LARRY ROBBINS | 6.31M | 4.23% | — | 6.31M | — | 6.31M | HC, IN | Delaware | 2017-02-14 | ↗ |
| 20 | JPMorgan Chase & Co. | 5.84M | 3.90% | — | 2.5K | — | — | HC | Delaware | 2016-12-06 | ↗ |
| 21 | Capital World Investors ** | 3.34M | 2.40% | 3.34M | — | 3.34M | — | IA | Delaware | 2018-08-10 | ↗ |
| 22 | The Guardian Life Insurance Company of America | 1.22M | 5.30% | 8.94M | 381.8K | 10.27M | 423.2K | IC, HC | Delaware | 2012-01-19 | ↗ |
| 23 | 95-1411037 | 13.00 | 2.10% | 2.73M | — | 2.73M | — | IA | Delaware | 2021-02-16 | ↗ |
Institutional Activity (13F)
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 14.26M +106.0K (+0.7%) | 3.65B -30.0M (-0.8%) | 11.84% +0.096 pp | 0.05% -0.002 pp | USD187.00 +37.0% | 84 qtrs — |
| 2 | DODGE & COX | 11.29M -47.8K (-0.4%) | 2.89B -58.0M (-2.0%) | 9.37% -0.033 pp | 1.56% -0.031 pp | USD302.69 -15.4% | 7 qtrs — |
| 3 | BLACKROCK, INC. | 10.63M +693.9K (+7.0%) | 2.72B +137.6M (+5.3%) | 8.83% +0.582 pp | 0.05% +0.001 pp | USD310.89 -17.6% | 6 qtrs — |
| 4 | CAPITAL INTERNATIONAL INVESTORS | 5.82M +3.1M (+113.9%) | 1.49B +782.6M (+110.6%) | 4.83% +2.573 pp | 0.23% +0.119 pp | USD258.02 -0.7% | 2 qtrs — |
| 5 | STATE STREET CORP | 5.46M +97.2K (+1.8%) | 1.40B +3.3M (+0.2%) | 4.54% +0.084 pp | 0.05% -0.002 pp | USD175.94 +45.6% | 51 qtrs — |
| 6 | JPMORGAN CHASE & CO | 4.60M -476.3K (-9.4%) | 1.18B -142.5M (-10.8%) | 3.82% -0.394 pp | 0.07% -0.005 pp | USD304.33 -15.8% | 51 qtrs — |
| 7 | MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 4.50M +1.0M (+28.9%) | 1.15B +244.2M (+26.9%) | 3.73% +0.838 pp | 0.37% +0.090 pp | USD265.19 -3.4% | 35 qtrs — |
| 8 | PZENA INVESTMENT MANAGEMENT LLC | 4.07M +41.1K (+1.0%) | 1.04B -5.8M (-0.5%) | 3.38% +0.035 pp | 3.12% -0.267 pp | USD322.15 -20.5% | 18 qtrs — |
| 9 | EAGLE CAPITAL MANAGEMENT LLC | 3.25M -711.1K (-17.9%) | 833.55M -198.2M (-19.2%) | 2.70% -0.588 pp | 2.60% -0.687 pp | USD342.84 -25.3% | 8 qtrs — |
| 10 | FMR LLC | 3.22M -44.8K (-1.4%) | 823.62M -24.6M (-2.9%) | 2.67% -0.033 pp | 0.04% -0.002 pp | USD308.61 -17.0% | 70 qtrs — |
| 11 | GEODE CAPITAL MANAGEMENT, LLC | 3.18M +23.7K (+0.8%) | 812.54M -6.5M (-0.8%) | 2.64% +0.022 pp | 0.05% -0.002 pp | USD250.61 +2.2% | 78 qtrs — |
| 12 | SESSA CAPITAL IM, L.P. | 2.32M +106.0K (+4.8%) | 593.94M +18.2M (+3.2%) | 1.93% +0.089 pp | 11.10% -2.523 pp | USD247.13 +3.6% | 5 qtrs — |
| 13 | INVESCO LTD. | 2.23M +189.7K (+9.3%) | 571.97M +40.3M (+7.6%) | 1.85% +0.159 pp | 0.09% +0.004 pp | USD339.13 -24.5% | 57 qtrs — |
| 14 | BANK OF NEW YORK MELLON CORP | 2.09M +376.8K (+21.9%) | 536.48M +89.6M (+20.0%) | 1.74% +0.314 pp | 0.10% +0.009 pp | USD276.02 -7.2% | 66 qtrs — |
| 15 | NORGES BANK | 1.78M +1.8M (+100.0%) | 456.63M +456.6M (+100.0%) | 1.48% +1.480 pp | 0.05% +0.049 pp | USD256.13 +0.0% | 1 qtrs NEW |
| 16 | MORGAN STANLEY | 1.47M -238.7K (-14.0%) | 375.40M -68.0M (-15.3%) | 1.22% -0.197 pp | 0.02% -0.004 pp | USD396.19 -35.4% | 51 qtrs — |
| 17 | HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 1.36M +1.1K (+0.1%) | 349.24M -5.2M (-1.5%) | 1.13% +0.002 pp | 1.04% -0.052 pp | USD289.24 -11.4% | 23 qtrs — |
| 18 | FRANKLIN RESOURCES INC | 1.26M +1.1M (+914.5%) | 321.61M +289.4M (+898.7%) | 1.04% +0.940 pp | 0.08% +0.071 pp | USD268.28 -4.5% | 36 qtrs — |
| 19 | NAYA CAPITAL MANAGEMENT UK LTD | 1.24M +461.6K (+59.1%) | 318.42M +115.1M (+56.6%) | 1.03% +0.384 pp | 23.98% +6.676 pp | USD258.67 -1.0% | 2 qtrs — |
| 20 | DIMENSIONAL FUND ADVISORS LP | 1.23M -21.1K (-1.7%) | 314.53M -10.3M (-3.2%) | 1.02% -0.016 pp | 0.07% -0.004 pp | USD151.91 +68.6% | 51 qtrs — |
| 21 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.21M +50.4K (+4.4%) | 309.34M +8.2M (+2.7%) | 1.00% +0.044 pp | 0.05% +0.000 pp | USD234.52 +9.2% | 100 qtrs — |
| 22 | WELLINGTON MANAGEMENT GROUP LLP | 1.20M +1.2M (+4,481.7%) | 306.46M +299.7M (+4,410.5%) | 0.99% +0.973 pp | 0.05% +0.053 pp | USD258.92 -1.1% | 81 qtrs — |
| 23 | UBS ASSET MANAGEMENT AMERICAS INC | 1.18M +9.5K (+0.8%) | 303.31M -2.3M (-0.8%) | 0.98% +0.010 pp | 0.06% -0.002 pp | USD277.44 -7.7% | 90 qtrs — |
| 24 | NORTHERN TRUST CORP | 1.15M -39.6K (-3.3%) | 295.31M -15.0M (-4.8%) | 0.96% -0.031 pp | 0.04% -0.002 pp | USD148.97 +71.9% | 51 qtrs — |
| 25 | NEWPORT TRUST CO | 985.7K -80.8K (-7.6%) | 252.48M -25.0M (-9.0%) | 0.82% -0.067 pp | 0.60% -0.028 pp | USD251.21 +2.0% | 33 qtrs — |
| 26 | GOLDMAN SACHS GROUP INC | 979.5K +52.1K (+5.6%) | 250.88M +9.6M (+4.0%) | 0.81% +0.044 pp | 0.03% +0.001 pp | USD326.09 -21.5% | 73 qtrs — |
| 27 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 971.5K -304.2K (-23.8%) | 248.83M -83.1M (-25.0%) | 0.81% -0.252 pp | 0.03% -0.009 pp | USD360.71 -29.0% | 51 qtrs — |
| 28 | SLATE PATH CAPITAL LP | 953.0K +953.0K (+100.0%) | 244.09M +244.1M (+100.0%) | 0.79% +0.792 pp | 3.29% +3.292 pp | USD256.13 +0.0% | 1 qtrs NEW |
| 29 | ALLIANZ ASSET MANAGEMENT GMBH | 883.9K +405.3K (+84.7%) | 226.40M +101.9M (+81.8%) | 0.73% +0.337 pp | 0.23% +0.090 pp | USD285.87 -10.4% | 51 qtrs — |
| 30 | LEGAL & GENERAL GROUP PLC | 876.3K -42.6K (-4.6%) | 224.45M -14.6M (-6.1%) | 0.73% -0.035 pp | 0.05% -0.004 pp | USD209.78 +22.1% | 75 qtrs — |
| 31 | BANK OF AMERICA CORP /DE/ | 844.6K +55.6K (+7.1%) | 216.32M +11.1M (+5.4%) | 0.70% +0.047 pp | 0.02% +0.002 pp | USD326.69 -21.6% | 52 qtrs — |
| 32 | ARTISAN PARTNERS LIMITED PARTNERSHIP | 684.8K -17.9K (-2.5%) | 175.39M -7.4M (-4.1%) | 0.57% -0.014 pp | 0.26% +0.003 pp | USD304.95 -16.0% | 8 qtrs — |
| 33 | CITADEL ADVISORS LLC | 654.8K -578.5K (-46.9%) | 167.71M -153.2M (-47.7%) | 0.54% -0.480 pp | 0.03% -0.024 pp | USD350.80 -27.0% | 38 qtrs — |
| 34 | HOLOCENE ADVISORS, LP | 611.9K +611.9K (+100.0%) | 156.73M +156.7M (+100.0%) | 0.51% +0.508 pp | 0.33% +0.329 pp | USD256.13 +0.0% | 20 qtrs — |
| 35 | ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 565.4K -391.3K (-40.9%) | 149.55M -86.5M (-36.7%) | 0.47% -0.324 pp | 0.24% -0.137 pp | USD334.53 -23.4% | 17 qtrs — |
| 36 | UBS GROUP AG | 578.4K +307.0K (+113.1%) | 148.14M +77.5M (+109.8%) | 0.48% +0.255 pp | 0.02% +0.013 pp | USD300.52 -14.8% | 45 qtrs — |
| 37 | HIGH GROUND INVESTMENT MANAGEMENT LLP | 494.0K -9.8K (-2.0%) | 126.52M -4.6M (-3.5%) | 0.41% -0.008 pp | 18.42% -3.353 pp | USD355.07 -27.9% | 13 qtrs — |
| 38 | BARROW HANLEY MEWHINNEY & STRAUSS LLC | 492.8K +400.9K (+436.2%) | 126.21M +102.3M (+427.9%) | 0.41% +0.333 pp | 0.42% +0.344 pp | USD278.30 -8.0% | 23 qtrs — |
| 39 | D. E. SHAW & CO., INC. | 453.5K -230.2K (-33.7%) | 116.15M -61.7M (-34.7%) | 0.38% -0.190 pp | 0.06% -0.037 pp | USD320.60 -20.1% | 69 qtrs — |
| 40 | DEUTSCHE BANK AG\ | 445.4K +29.4K (+7.1%) | 114.09M +5.9M (+5.4%) | 0.37% +0.025 pp | 0.04% +0.001 pp | USD323.76 -20.9% | 50 qtrs — |
| 41 | POINT72 ASSET MANAGEMENT, L.P. | 445.0K +307.8K (+224.3%) | 113.98M +78.3M (+219.3%) | 0.37% +0.256 pp | 0.13% +0.068 pp | USD261.66 -2.1% | 9 qtrs — |
| 42 | JANE STREET GROUP, LLC | 438.4K -166.2K (-27.5%) | 112.29M -45.0M (-28.6%) | 0.36% -0.138 pp | 0.02% -0.007 pp | USD285.32 -10.2% | 6 qtrs — |
| 43 | VICTORY CAPITAL MANAGEMENT INC | 434.0K +342.6K (+374.6%) | 111.17M +87.4M (+367.2%) | 0.36% +0.285 pp | 0.06% +0.049 pp | USD260.20 -1.6% | 42 qtrs — |
| 44 | AMUNDI | 417.9K +111.3K (+36.3%) | 107.03M +16.5M (+18.2%) | 0.35% +0.093 pp | 0.03% +0.000 pp | USD409.16 -37.4% | 19 qtrs — |
| 45 | NUVEEN, LLC | 390.5K +1.8K (+0.5%) | 100.03M -1.1M (-1.1%) | 0.32% +0.002 pp | 0.03% -0.001 pp | USD264.56 -3.2% | 4 qtrs — |
| 46 | VOYA INVESTMENT MANAGEMENT LLC | 387.8K +97.6K (+33.6%) | 99.23M +23.7M (+31.4%) | 0.32% +0.081 pp | 0.10% +0.022 pp | USD276.11 -7.2% | 51 qtrs — |
| 47 | NEUBERGER BERMAN GROUP LLC | 385.8K -145.0K (-27.3%) | 98.82M -39.3M (-28.4%) | 0.32% -0.120 pp | 0.07% -0.027 pp | USD263.17 -2.7% | 67 qtrs — |
| 48 | RUSSELL INVESTMENTS GROUP, LTD. | 367.7K +9.7K (+2.7%) | 94.25M +1.2M (+1.3%) | 0.31% +0.009 pp | 0.10% -0.003 pp | USD341.71 -25.0% | 37 qtrs — |
| 49 | BANK OF NOVA SCOTIA | 360.8K +283.5K (+366.8%) | 92.41M +72.3M (+359.6%) | 0.30% +0.235 pp | 0.14% +0.101 pp | USD260.88 -1.8% | 51 qtrs — |
| 50 | SUMITOMO MITSUI TRUST HOLDINGS, INC. | 354.4K +59.2K (+20.1%) | 90.78M +14.0M (+18.2%) | 0.29% +0.049 pp | 0.05% +0.009 pp | USD252.03 +1.6% | 59 qtrs — |
| 51 | BARCLAYS PLC | 353.6K -3.4K (-1.0%) | 90.56M -22.5M (-19.9%) | 0.29% -0.003 pp | 0.02% -0.007 pp | USD396.28 -35.4% | 51 qtrs — |
| 52 | PRICE T ROWE ASSOCIATES INC /MD/ | 351.5K -107.0K (-23.3%) | 90.02M -29.3M (-24.5%) | 0.29% -0.089 pp | 0.01% -0.003 pp | USD332.81 -23.0% | 75 qtrs — |
| 53 | AMERIPRISE FINANCIAL INC | 339.4K +52.2K (+18.2%) | 86.95M +12.2M (+16.3%) | 0.28% +0.044 pp | 0.02% +0.003 pp | USD310.33 -17.5% | 51 qtrs — |
| 54 | HSBC HOLDINGS PLC | 330.8K +27.5K (+9.1%) | 85.11M +6.2M (+7.9%) | 0.27% +0.023 pp | 0.04% 0.000 pp | USD366.67 -30.1% | 56 qtrs — |
| 55 | SWISS NATIONAL BANK | 329.5K -18.4K (-5.3%) | 84.40M -6.1M (-6.8%) | 0.27% -0.015 pp | 0.05% -0.002 pp | USD230.23 +11.2% | 51 qtrs — |
| 56 | BRANDYWINE GLOBAL INVESTMENT MANAGEMENT, LLC | 313.9K +75.5K (+31.7%) | 80.39M +18.4M (+29.6%) | 0.26% +0.063 pp | 0.54% +0.114 pp | USD255.11 +0.4% | 5 qtrs — |
| 57 | ABRDN PLC | 283.8K +43.4K (+18.1%) | 72.68M +10.2M (+16.3%) | 0.24% +0.036 pp | 0.11% +0.014 pp | USD320.62 -20.1% | 34 qtrs — |
| 58 | AQR CAPITAL MANAGEMENT LLC | 283.1K -186.4K (-39.7%) | 72.51M -49.6M (-40.6%) | 0.24% -0.154 pp | 0.04% -0.040 pp | USD270.68 -5.4% | 92 qtrs — |
| 59 | MITSUBISHI UFJ KOKUSAI ASSET MANAGEMENT CO., LTD. | 250.3K +10.0K (+4.1%) | 66.21M +3.7M (+5.9%) | 0.21% +0.008 pp | 0.04% 0.000 pp | USD343.40 -25.4% | 58 qtrs — |
| 60 | RHUMBLINE ADVISERS | 245.9K -5.4K (-2.2%) | 62.99M -2.4M (-3.7%) | 0.20% -0.004 pp | 0.05% -0.002 pp | USD225.40 +13.6% | 55 qtrs — |
| 61 | — | 256.1K +256.1K (+100.0%) | 60.97M +61.0M (+100.0%) | 0.21% +0.213 pp | 1.54% +1.542 pp | USD256.13 +0.0% | 1 qtrs NEW |
| 62 | BNP PARIBAS ARBITRAGE, SNC | 233.5K -2.8K (-1.2%) | 59.81M -1.7M (-2.7%) | 0.19% -0.002 pp | 0.03% -0.006 pp | USD338.88 -24.4% | 51 qtrs — |
| 63 | CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 226.4K -5.1K (-2.2%) | 57.98M -2.2M (-3.7%) | 0.19% -0.004 pp | 0.03% -0.003 pp | USD329.05 -22.2% | 53 qtrs — |
| 64 | ARGA INVESTMENT MANAGEMENT, LP | 223.1K +1.1K (+0.5%) | 57.13M -602.8K (-1.0%) | 0.19% +0.001 pp | 1.56% +0.027 pp | USD256.35 -0.1% | 3 qtrs — |
| 65 | ACADIAN ASSET MANAGEMENT LLC | 222.8K -62.4K (-21.9%) | 57.05M -17.1M (-23.1%) | 0.19% -0.052 pp | 0.09% -0.036 pp | USD250.08 +2.4% | 4 qtrs — |
| 66 | FEDERATED HERMES, INC. | 218.4K -19.1K (-8.0%) | 55.95M -5.8M (-9.5%) | 0.18% -0.016 pp | 0.09% -0.016 pp | USD269.82 -5.1% | 54 qtrs — |
| 67 | FIL LTD | 218.0K +6.8K (+3.2%) | 55.84M +876.4K (+1.6%) | 0.18% +0.006 pp | 0.04% -0.001 pp | USD289.51 -11.5% | 66 qtrs — |
| 68 | ENSIGN PEAK ADVISORS, INC | 217.7K -59.4K (-21.4%) | 55.76M -16.3M (-22.6%) | 0.18% -0.049 pp | 0.10% -0.020 pp | USD393.90 -35.0% | 25 qtrs — |
| 69 | RETIREMENT SYSTEMS OF ALABAMA | 213.0K -69.0 (0.0%) | 54.56M -878.5K (-1.6%) | 0.18% +0.000 pp | 0.18% -0.007 pp | USD257.09 -0.4% | 52 qtrs — |
| 70 | WALLEYE TRADING LLC | 204.4K +16.4K (+8.7%) | 52.35M +3.4M (+7.0%) | 0.17% +0.014 pp | 0.07% +0.000 pp | USD302.98 -15.5% | 77 qtrs — |
| 71 | JANUS HENDERSON GROUP PLC | 201.4K +8.1K (+4.2%) | 51.60M +1.3M (+2.6%) | 0.17% +0.007 pp | 0.02% +0.000 pp | USD317.12 -19.2% | 85 qtrs — |
| 72 | NATIONAL PENSION SERVICE | 200.0K +10.4K (+5.5%) | 51.24M +1.9M (+3.9%) | 0.17% +0.009 pp | 0.04% 0.000 pp | USD309.73 -17.3% | 46 qtrs — |
| 73 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 185.9K -115.2K (-38.3%) | 47.62M -30.7M (-39.2%) | 0.15% -0.096 pp | 0.03% -0.022 pp | USD253.88 +0.9% | 18 qtrs — |
| 74 | BANK OF MONTREAL /CAN/ | 176.5K -25.4K (-12.6%) | 45.20M -7.3M (-13.9%) | 0.15% -0.021 pp | 0.02% -0.005 pp | USD353.50 -27.5% | 51 qtrs — |
| 75 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 175.7K -5.9K (-3.2%) | 45.01M -2.2M (-4.7%) | 0.15% -0.005 pp | 0.05% -0.003 pp | USD159.68 +60.4% | 52 qtrs — |
| 76 | MAPLE ROCK CAPITAL PARTNERS INC. | 172.7K -110.6K (-39.0%) | 44.23M -29.5M (-40.0%) | 0.14% -0.092 pp | 1.46% -1.447 pp | USD261.80 -2.2% | 4 qtrs — |
| 77 | WELLS FARGO & COMPANY/MN | 170.8K +52.7K (+44.6%) | 43.75M +13.0M (+42.3%) | 0.14% +0.044 pp | 0.01% +0.002 pp | USD260.22 -1.6% | 57 qtrs — |
| 78 | LONG FOCUS CAPITAL MANAGEMENT, LLC | 169.5K +38.0K (+28.9%) | 43.41M +9.2M (+26.9%) | 0.14% +0.032 pp | 1.14% +0.012 pp | USD259.26 -1.2% | 2 qtrs — |
| 79 | VIRGINIA RETIREMENT SYSTEMS ET AL | 161.9K -26.8K (-14.2%) | 41.47M -7.6M (-15.5%) | 0.13% -0.022 pp | 0.25% -0.072 pp | USD256.05 +0.0% | 4 qtrs — |
| 80 | SOUTH DAKOTA INVESTMENT COUNCIL | 161.4K +12.5K (+8.4%) | 41.34M +2.6M (+6.7%) | 0.13% +0.011 pp | 0.79% +0.034 pp | USD294.56 -13.0% | 46 qtrs — |
| 81 | CANADA PENSION PLAN INVESTMENT BOARD | 152.4K +6.6K (+4.5%) | 39.03M +1.1M (+2.9%) | 0.13% +0.006 pp | 0.03% -0.001 pp | USD321.60 -20.4% | 52 qtrs — |
| 82 | ALLIANCEBERNSTEIN L.P. | 151.9K +20.9K (+16.0%) | 38.90M +4.8M (+14.2%) | 0.13% +0.017 pp | 0.01% +0.002 pp | USD353.15 -27.5% | 61 qtrs — |
| 83 | AMF TJANSTEPENSION AB | 151.6K +— (+0.0%) | 38.82M -612.3K (-1.6%) | 0.13% +0.000 pp | 0.24% -0.009 pp | USD252.52 +1.4% | 41 qtrs — |
| 84 | SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 150.4K -12.2K (-7.5%) | 38.52M -3.8M (-8.9%) | 0.12% -0.010 pp | 0.59% -0.076 pp | USD244.48 +4.8% | 3 qtrs — |
| 85 | JUPITER ASSET MANAGEMENT LTD | 147.5K +147.5K (+100.0%) | 37.77M +37.8M (+100.0%) | 0.12% +0.122 pp | 0.30% +0.302 pp | USD256.13 +0.0% | 1 qtrs NEW |
| 86 | ROYAL BANK OF CANADA | 145.9K +9.1K (+6.7%) | 37.36M +1.8M (+5.0%) | 0.12% +0.008 pp | 0.01% +0.000 pp | USD421.38 -39.2% | 51 qtrs — |
| 87 | PRINCIPAL FINANCIAL GROUP INC | 135.3K -352.0 (-0.3%) | 34.65M -638.1K (-1.8%) | 0.11% 0.000 pp | 0.02% 0.000 pp | USD230.30 +11.2% | 81 qtrs — |
| 88 | CITIGROUP INC | 131.4K -98.7K (-42.9%) | 33.66M -26.2M (-43.8%) | 0.11% -0.082 pp | 0.01% -0.012 pp | USD320.33 -20.0% | 108 qtrs — |
| 89 | NEW YORK STATE COMMON RETIREMENT FUND | 128.7K +17.9K (+16.2%) | 32.97M +4.1M (+14.3%) | 0.11% +0.015 pp | 0.04% +0.007 pp | USD186.93 +37.0% | 103 qtrs — |
| 90 | CAPITAL FUND MANAGEMENT S.A. | 128.0K +46.7K (+57.5%) | 32.78M +11.6M (+55.0%) | 0.11% +0.039 pp | 0.09% +0.036 pp | USD250.82 +2.1% | 4 qtrs — |
Insider Activity
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-16 | Field Robert Stuart | Director | — | — | Humana Common | 0 | 0.00 | — | 0 | D | ↗ |
| 2026-04-01 | Shetty Sanjay K | Officer | M-Exempt | A | Humana Common | 887 | 0.00 | — | 12,544 | D | ↗ |
| 2026-03-31 | Renaudin George II | Officer | J-Other | A | Phantom Stock Units | 25 | 0.00 | — | 199 | I | ↗ |
| 2026-03-31 | HILZINGER KURT J | Director | A-Award | A | Restricted Stock Units | 536 | 0.00 | — | 16,301 | D | ↗ |
| 2026-02-24 | Ventura Joseph C | Officer | F-InKind | D | Humana Common | 478 | 177.08 | 84.6K | 17,087 | D | ↗ |
| 2026-02-24 | Renaudin George II | Officer | F-InKind | D | Humana Common | 419 | 177.08 | 74.2K | 16,075 | D | ↗ |
| 2026-02-24 | Felter John-Paul W. | Officer | F-InKind | D | Humana Common | 84 | 177.08 | 14.9K | 7,484 | D | ↗ |
| 2026-02-23 | Shetty Sanjay K | Officer | P-Purchase | A | Humana Common | 810 | 185.21 | 150.0K | 11,657 | D | ↗ |
| 2026-02-23 | Felter John-Paul W. | Officer | A-Award | A | Humana Common | 5,669 | 0.00 | — | 7,403 | D | ↗ |
| 2026-02-21 | Dintenfass David | Officer | M-Exempt | A | Humana Common | 3,858 | 0.00 | — | 15,316 | D | ↗ |
| 2026-02-13 | Mellet Celeste | Officer | M-Exempt | A | Humana Common | 7,763 | 0.00 | — | 28,454 | D | ↗ |
| 2026-02-13 | Mehta Japan | Officer | F-InKind | D | Humana Common | 430 | 181.46 | 78.0K | 7,728 | D | ↗ |
| 2026-02-12 | Martin Aaron | Officer | A-Award | A | Humana Common | 17,031 | 0.00 | — | 17,031 | D | ↗ |
| 2026-01-26 | Martin Aaron | Officer | — | — | Humana Common | 0 | 0.00 | — | 0 | D | ↗ |
| 2026-01-08 | Rechtin James A. | Officer | M-Exempt | A | Humana Common | 2,183 | 0.00 | — | 29,285 | I | ↗ |
| 2026-01-02 | Smith Gordon | Director | A-Award | A | Restricted Stock Units | 766 | 0.00 | — | 1,549 | D | ↗ |
| 2026-01-02 | Mesquita Jorge S. | Director | A-Award | A | Humana Common | 766 | 0.00 | — | 4,127 | I | ↗ |
| 2026-01-02 | Klevorn Marcy S | Director | A-Award | A | Restricted Stock Units | 766 | 0.00 | — | 2,771 | D | ↗ |
| 2026-01-02 | KATZ KAREN | Director | A-Award | A | Restricted Stock Units | 766 | 0.00 | — | 3,627 | D | ↗ |
| 2026-01-02 | HILZINGER KURT J | Director | A-Award | A | Restricted Stock Units | 766 | 0.00 | — | 24,800 | D | ↗ |
| 2026-01-02 | Garratt John W | Director | A-Award | A | Restricted Stock Units | 766 | 0.00 | — | 1,929 | D | ↗ |
| 2026-01-02 | Frederick Wayne A.I. | Director | A-Award | A | Restricted Stock Units | 766 | 0.00 | — | 3,174 | D | ↗ |
| 2026-01-02 | Feinberg David T | Director | A-Award | A | Humana Common | 766 | 0.00 | — | 1,207 | D | ↗ |
| 2026-01-02 | DAMELIO FRANK A | Director | A-Award | A | Restricted Stock Units | 766 | 0.00 | — | 26,826 | D | ↗ |
| 2026-01-02 | Bono Raquel C. | Director | A-Award | A | Restricted Stock Units | 766 | 0.00 | — | 3,174 | D | ↗ |
| 2026-01-01 | O'Hara Michelle A. | Officer | M-Exempt | A | Humana Common | 2,353 | 0.00 | — | 10,634 | D | ↗ |
| 2025-12-31 | Smith Gordon | Director | A-Award | A | Restricted Stock Units | 122 | 0.00 | — | 500 | D | ↗ |
| 2025-12-31 | Klevorn Marcy S | Director | A-Award | A | Restricted Stock Units | 28 | 0.00 | — | 53 | D | ↗ |
| 2025-12-31 | KATZ KAREN | Director | A-Award | A | Restricted Stock Units | 49 | 0.00 | — | 124 | D | ↗ |
| 2025-12-31 | HILZINGER KURT J | Director | A-Award | A | Restricted Stock Units | 611 | 0.00 | — | 3,364 | D | ↗ |
| 2025-12-31 | Garratt John W | Director | A-Award | A | Restricted Stock Units | 16 | 0.00 | — | 18 | D | ↗ |
| 2025-12-31 | Frederick Wayne A.I. | Director | A-Award | A | Restricted Stock Units | 35 | 0.00 | — | 73 | D | ↗ |
| 2025-12-31 | Feinberg David T | Director | A-Award | A | Restricted Stock Units | 70 | 0.00 | — | 708 | D | ↗ |
| 2025-12-31 | Bono Raquel C. | Director | A-Award | A | Restricted Stock Units | 34 | 0.00 | — | 72 | D | ↗ |
| 2025-12-15 | Ventura Joseph C | Officer | M-Exempt | A | Humana Common | 360 | 0.00 | — | 16,694 | D | ↗ |
| 2025-12-15 | Shetty Sanjay K | Officer | M-Exempt | A | Humana Common | 1,968 | 0.00 | — | 11,566 | D | ↗ |
| 2025-12-15 | Renaudin George II | Officer | F-InKind | D | Humana Common | 142 | 270.16 | 38.4K | 15,459 | D | ↗ |
| 2025-12-15 | Rechtin James A. | Officer | F-InKind | D | Humana Common | 3,372 | 270.16 | 911.0K | 27,102 | I | ↗ |
| 2025-12-15 | O'Hara Michelle A. | Officer | F-InKind | D | Humana Common | 632 | 270.16 | 170.7K | 10,634 | D | ↗ |
| 2025-12-15 | Mellet Celeste | Officer | M-Exempt | A | Humana Common | 2,128 | 0.00 | — | 29,676 | D | ↗ |
| 2025-12-15 | Mehta Japan | Officer | F-InKind | D | Humana Common | 470 | 270.16 | 127.0K | 8,158 | D | ↗ |
| 2025-12-15 | Felter John-Paul W. | Officer | M-Exempt | D | Restricted Stock Units | 115 | 0.00 | — | 0 | D | ↗ |
| 2025-12-15 | Dintenfass David | Officer | F-InKind | D | Humana Common | 918 | 270.16 | 248.0K | 15,316 | D | ↗ |
| 2025-11-01 | Smith Gordon | Director | M-Exempt | A | Humana Common | 765 | 0.00 | — | 765 | D | ↗ |
| 2025-10-01 | Renaudin George II | Officer | M-Exempt | A | Humana Common | 609 | 0.00 | — | 16,311 | D | ↗ |
| 2025-09-30 | Smith Gordon | Director | A-Award | A | Restricted Stock Units | 124 | 0.00 | — | 378 | D | ↗ |
| 2025-09-30 | HILZINGER KURT J | Director | A-Award | A | Restricted Stock Units | 364 | 0.00 | — | 15,408 | D | ↗ |
| 2025-09-30 | Feinberg David T | Director | A-Award | A | Restricted Stock Units | 69 | 0.00 | — | 638 | D | ↗ |
| 2025-08-01 | Felter John-Paul W. | Officer | F-InKind | D | Humana Common | 97 | 248.42 | 24.1K | 1,881 | D | ↗ |
| 2025-06-30 | Smith Gordon | Director | A-Award | A | Restricted Stock Units | 136 | 0.00 | — | 254 | D | ↗ |
| 2025-06-30 | HILZINGER KURT J | Director | A-Award | A | Restricted Stock Units | 399 | 0.00 | — | 15,044 | D | ↗ |
| 2025-06-30 | Feinberg David T | Director | A-Award | A | Restricted Stock Units | 76 | 0.00 | — | 569 | D | ↗ |
| 2025-05-14 | Rechtin James A. | Officer | P-Purchase | A | Humana Common | 6,530 | 229.25 | 1.50M | 30,474 | I | ↗ |
| 2025-03-31 | Smith Gordon | Director | A-Award | A | Restricted Stock Units | 118 | 0.00 | — | 118 | D | ↗ |
| 2025-03-31 | HILZINGER KURT J | Director | A-Award | A | Restricted Stock Units | 345 | 0.00 | — | 14,645 | D | ↗ |
| 2025-03-31 | Feinberg David T | Director | A-Award | A | Restricted Stock Units | 66 | 0.00 | — | 493 | D | ↗ |
| 2025-03-27 | Renaudin George II | Officer | J-Other | A | Phantom Stock Units | 5 | 0.00 | — | 170 | I | ↗ |
| 2025-02-24 | Ventura Joseph C | Officer | A-Award | A | Humana Common | 4,438 | 0.00 | — | 17,267 | D | ↗ |
| 2025-02-24 | Shetty Sanjay K | Officer | A-Award | A | Humana Common | 4,205 | 0.00 | — | 11,566 | D | ↗ |
| 2025-02-24 | Renaudin George II | Officer | A-Award | A | Humana Common | 4,516 | 0.00 | — | 15,702 | D | ↗ |
| 2025-02-24 | Rechtin James A. | Officer | A-Award | A | Humana Common | 19,037 | 0.00 | — | 23,944 | I | ↗ |
| 2025-02-24 | O'Hara Michelle A. | Officer | A-Award | A | Humana Common | 4,205 | 0.00 | — | 11,266 | D | ↗ |
| 2025-02-24 | Mellet Celeste | Officer | A-Award | A | Humana Common | 6,385 | 0.00 | — | 29,676 | D | ↗ |
| 2025-02-24 | Mehta Japan | Officer | A-Award | A | Humana Common | 3,582 | 0.00 | — | 8,628 | D | ↗ |
| 2025-02-24 | Felter John-Paul W. | Officer | A-Award | A | Humana Common | 876 | 0.00 | — | 1,767 | D | ↗ |
| 2025-02-24 | Dintenfass David | Officer | A-Award | A | Humana Common | 4,360 | 0.00 | — | 16,234 | D | ↗ |
| 2025-02-24 | Agrawal Vishal | Officer | A-Award | A | Humana Common | 3,270 | 0.00 | — | 16,717 | D | ↗ |
| 2025-02-21 | Ventura Joseph C | Officer | F-InKind | D | Humana Common | 1,065 | 258.58 | 275.4K | 12,829 | D | ↗ |
| 2025-02-21 | Renaudin George II | Officer | F-InKind | D | Humana Common | 300 | 258.58 | 77.6K | 11,186 | D | ↗ |
| 2025-02-21 | Dintenfass David | Officer | F-InKind | D | Humana Common | 1,175 | 258.58 | 303.8K | 11,874 | D | ↗ |
| 2025-02-21 | Agrawal Vishal | Officer | M-Exempt | A | Humana Common | 1,970 | 0.00 | — | 14,352 | D | ↗ |
| 2025-02-13 | Mellet Celeste | Officer | A-Award | A | Humana Common | 23,291 | 0.00 | — | 23,291 | D | ↗ |
| 2025-02-13 | Mehta Japan | Officer | A-Award | A | Humana Common | 5,046 | 0.00 | — | 5,046 | D | ↗ |
| 2025-02-01 | Mehta Japan | Officer | — | — | Humana Common | 0 | 0.00 | — | 0 | D | ↗ |
| 2025-01-11 | Mellet Celeste | Officer | — | — | Humana Common | 0 | 0.00 | — | 0 | D | ↗ |
| 2025-01-08 | Rechtin James A. | Officer | M-Exempt | A | Humana Common | 2,182 | 0.00 | — | 5,885 | I | ↗ |
| 2025-01-02 | Smith Gordon | Director | A-Award | A | Restricted Stock Units | 783 | 0.00 | — | 783 | D | ↗ |
| 2025-01-02 | SMITH BRAD D | Director | A-Award | A | Humana Common | 783 | 0.00 | — | 1,169 | D | ↗ |
| 2025-01-02 | Mesquita Jorge S. | Director | A-Award | A | Humana Common | 783 | 0.00 | — | 3,361 | I | ↗ |
| 2025-01-02 | Klevorn Marcy S | Director | A-Award | A | Restricted Stock Units | 783 | 0.00 | — | 2,005 | D | ↗ |
| 2025-01-02 | KATZ KAREN | Director | A-Award | A | Restricted Stock Units | 783 | 0.00 | — | 2,861 | D | ↗ |
| 2025-01-02 | HILZINGER KURT J | Director | A-Award | A | Restricted Stock Units | 783 | 0.00 | — | 24,034 | D | ↗ |
| 2025-01-02 | Garratt John W | Director | A-Award | A | Restricted Stock Units | 783 | 0.00 | — | 1,163 | D | ↗ |
| 2025-01-02 | Frederick Wayne A.I. | Director | A-Award | A | Restricted Stock Units | 783 | 0.00 | — | 2,408 | D | ↗ |
| 2025-01-02 | Feinberg David T | Director | A-Award | A | Restricted Stock Units | 783 | 0.00 | — | 1,593 | D | ↗ |
| 2025-01-02 | DAMELIO FRANK A | Director | A-Award | A | Restricted Stock Units | 783 | 0.00 | — | 26,060 | D | ↗ |
| 2025-01-02 | Bono Raquel C. | Director | A-Award | A | Restricted Stock Units | 783 | 0.00 | — | 2,408 | D | ↗ |
| 2025-01-01 | O'Hara Michelle A. | Officer | A-Award | A | Humana Common | 7,061 | 0.00 | — | 7,061 | D | ↗ |
| 2024-12-31 | SMITH BRAD D | Director | A-Award | A | Restricted Stock Units | 231 | 0.00 | — | 771 | D | ↗ |
| 2024-12-31 | Klevorn Marcy S | Director | A-Award | A | Restricted Stock Units | 17 | 0.00 | — | 25 | D | ↗ |
| 2024-12-31 | KATZ KAREN | Director | A-Award | A | Restricted Stock Units | 38 | 0.00 | — | 75 | D | ↗ |
| 2024-12-31 | Huval Timothy S. | Officer | G-Gift | D | Humana Common | 1,070 | 0.00 | — | 7,111 | D | ↗ |
| 2024-12-31 | HILZINGER KURT J | Director | A-Award | A | Restricted Stock Units | 673 | 0.00 | — | 14,300 | D | ↗ |
| 2024-12-31 | Frederick Wayne A.I. | Director | A-Award | A | Restricted Stock Units | 23 | 0.00 | — | 38 | D | ↗ |
| 2024-12-31 | Feinberg David T | Director | A-Award | A | Restricted Stock Units | 14 | 0.00 | — | 17 | D | ↗ |
| 2024-12-31 | Diamond Susan M | Officer | J-Other | A | Phantom Stock Units | 1 | 0.00 | — | 332 | I | ↗ |
| 2024-12-31 | Bono Raquel C. | Director | A-Award | A | Restricted Stock Units | 23 | 0.00 | — | 38 | D | ↗ |
| 2024-12-15 | Ventura Joseph C | Officer | M-Exempt | A | Humana Common | 359 | 0.00 | — | 11,750 | D | ↗ |
| 2024-12-15 | Shetty Sanjay K | Officer | M-Exempt | D | Restricted Stock Units | 308 | 0.00 | — | 308 | D | ↗ |
| 2024-12-15 | Renaudin George II | Officer | M-Exempt | A | Humana Common | 230 | 0.00 | — | 10,554 | D | ↗ |
| 2024-12-15 | Rechtin James A. | Officer | F-InKind | D | Humana Common | 392 | 271.68 | 106.5K | 3,693 | D | ↗ |
| 2024-12-15 | Huval Timothy S. | Officer | F-InKind | D | Humana Common | 156 | 271.68 | 42.4K | 11,884 | D | ↗ |
| 2024-12-15 | Felter John-Paul W. | Officer | M-Exempt | D | Restricted Stock Units | 114 | 0.00 | — | 115 | D | ↗ |
| 2024-12-15 | Dintenfass David | Officer | F-InKind | D | Humana Common | 261 | 271.68 | 70.9K | 13,049 | D | ↗ |
| 2024-12-15 | Diamond Susan M | Officer | M-Exempt | A | Humana Common | 512 | 0.00 | — | 20,079 | D | ↗ |
| 2024-12-15 | Deshpande Samir | Officer | F-InKind | D | Humana Common | 221 | 271.68 | 60.0K | 13,639 | D | ↗ |
| 2024-12-15 | Agrawal Vishal | Officer | M-Exempt | A | Humana Common | 310 | 0.00 | — | 12,522 | D | ↗ |
| 2024-11-01 | Smith Gordon | Director | A-Award | A | Humana Common | 765 | 0.00 | — | 765 | D | ↗ |
| 2024-10-23 | Smith Gordon | Director | — | — | Humana Common | 0 | 0.00 | — | 0 | D | ↗ |
| 2024-09-30 | SMITH BRAD D | Director | A-Award | A | Restricted Stock Units | 102 | 0.00 | — | 540 | D | ↗ |
| 2024-09-30 | HILZINGER KURT J | Director | A-Award | A | Restricted Stock Units | 295 | 0.00 | — | 13,627 | D | ↗ |
| 2024-09-30 | Fleming William Kevin | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-09-30 | Feinberg David T | Director | A-Award | A | Restricted Stock Units | 57 | 0.00 | — | 296 | D | ↗ |
| 2024-09-01 | Renaudin George II | Officer | M-Exempt | A | Humana Common | 1,241 | 0.00 | — | 10,864 | — | ↗ |
| 2024-08-01 | Felter John-Paul W. | Officer | F-InKind | D | Humana Common | 63 | 357.33 | 22.5K | 860 | — | ↗ |
| 2024-08-01 | Diamond Susan M | Officer | M-Exempt | A | Humana Common | 311 | 0.00 | — | 20,102 | — | ↗ |
| 2024-07-01 | BROUSSARD BRUCE D | Director / Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-06-28 | SMITH BRAD D | Director | A-Award | A | Restricted Stock Units | 84 | 0.00 | — | 438 | — | ↗ |
| 2024-06-28 | HILZINGER KURT J | Director | A-Award | A | Restricted Stock Units | 246 | 0.00 | — | 13,332 | — | ↗ |
| 2024-06-28 | Feinberg David T | Director | A-Award | A | Restricted Stock Units | 47 | 0.00 | — | 239 | — | ↗ |
| 2024-04-18 | McDonald William J. | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-03-28 | SMITH BRAD D | Director | A-Award | A | Restricted Stock Units | 92 | 0.00 | — | 354 | — | ↗ |
| 2024-03-28 | Renaudin George II | Officer | J-Other | A | Phantom Stock Units | 8 | 0.00 | — | 162 | — | ↗ |
| 2024-03-28 | HILZINGER KURT J | Director | A-Award | A | Restricted Stock Units | 270 | 0.00 | — | 13,086 | — | ↗ |
| 2024-03-28 | Feinberg David T | Director | A-Award | A | Restricted Stock Units | 51 | 0.00 | — | 192 | — | ↗ |
| 2024-02-22 | Ventura Joseph C | Officer | F-InKind | D | Humana Common | 1,153 | 366.11 | 422.1K | 7,028 | — | ↗ |
| 2024-02-22 | Renaudin George II | Officer | M-Exempt | A | Humana Common | 1,104 | 0.00 | — | 2,651 | — | ↗ |
| 2024-02-22 | Huval Timothy S. | Officer | F-InKind | D | Humana Common | 1,284 | 366.11 | 470.1K | 7,390 | — | ↗ |
| 2024-02-22 | Fleming William Kevin | Officer | F-InKind | D | Humana Common | 1,226 | 366.11 | 448.8K | 10,327 | — | ↗ |
| 2024-02-22 | Diamond Susan M | Officer | M-Exempt | A | Humana Common | 3,356 | 0.00 | — | 7,436 | — | ↗ |
| 2024-02-22 | Deshpande Samir | Officer | F-InKind | D | Humana Common | 1,302 | 366.11 | 476.7K | 12,396 | — | ↗ |
| 2024-02-22 | BROUSSARD BRUCE D | Director / Officer | F-InKind | D | Humana Common | 8,473 | 366.11 | 3.10M | 88,344 | — | ↗ |
| 2024-02-22 | Agrawal Vishal | Officer | F-InKind | D | Humana Common | 959 | 366.11 | 351.1K | 10,886 | — | ↗ |
| 2024-02-21 | Ventura Joseph C | Officer | A-Award | A | Options | 6,572 | 367.21 | 2.41M | 6,572 | — | ↗ |
| 2024-02-21 | Shetty Sanjay K | Officer | A-Award | A | Options | 6,572 | 367.21 | 2.41M | 6,572 | — | ↗ |
| 2024-02-21 | Renaudin George II | Officer | A-Award | A | Humana Common | 7,250 | 0.00 | — | 9,623 | — | ↗ |
| 2024-02-21 | Rechtin James A. | Officer | A-Award | A | Options | 15,772 | 367.21 | 5.79M | 15,772 | — | ↗ |
| 2024-02-21 | Huval Timothy S. | Officer | A-Award | A | Options | 6,309 | 367.21 | 2.32M | 6,309 | — | ↗ |
| 2024-02-21 | Fleming William Kevin | Officer | A-Award | A | Humana Common | 1,396 | 0.00 | — | 11,723 | — | ↗ |
| 2024-02-21 | Felter John-Paul W. | Officer | A-Award | A | Humana Common | 490 | 0.00 | — | 713 | — | ↗ |
| 2024-02-21 | Dintenfass David | Officer | A-Award | A | Options | 51,389 | 367.21 | 18.87M | 51,389 | — | ↗ |
| 2024-02-21 | Diamond Susan M | Officer | A-Award | A | Humana Common | 13,480 | 0.00 | — | 19,791 | — | ↗ |
| 2024-02-21 | Deshpande Samir | Officer | A-Award | A | Humana Common | 1,464 | 0.00 | — | 13,860 | — | ↗ |
| 2024-02-21 | BROUSSARD BRUCE D | Director / Officer | A-Award | A | Humana Common | 21,786 | 0.00 | — | 110,130 | — | ↗ |
| 2024-02-21 | Agrawal Vishal | Officer | A-Award | A | Humana Common | 1,362 | 0.00 | — | 12,248 | — | ↗ |
| 2024-02-20 | Mesquita Jorge S. | Director | P-Purchase | A | Humana Common | 545 | 367.09 | 200.1K | 2,578 | — | ↗ |
| 2024-02-05 | Dintenfass David | Officer | — | D | Humana Common | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-01-08 | Rechtin James A. | Officer | A-Award | A | Restricted Stock Units | 6,548 | 0.00 | — | 6,548 | — | ↗ |
| 2024-01-02 | SMITH BRAD D | Director | A-Award | A | Restricted Stock Units | 430 | 0.00 | — | 430 | — | ↗ |
| 2024-01-02 | Mesquita Jorge S. | Director | A-Award | A | Humana Common | 430 | 0.00 | — | 2,033 | — | ↗ |
| 2024-01-02 | McDonald William J. | Director | A-Award | A | Restricted Stock Units | 430 | 0.00 | — | 430 | — | ↗ |
| 2024-01-02 | Klevorn Marcy S | Director | A-Award | A | Restricted Stock Units | 430 | 0.00 | — | 430 | — | ↗ |
| 2024-01-02 | KATZ KAREN | Director | A-Award | A | Restricted Stock Units | 430 | 0.00 | — | 430 | — | ↗ |
| 2024-01-02 | HILZINGER KURT J | Director | A-Award | A | Restricted Stock Units | 430 | 0.00 | — | 430 | — | ↗ |
| 2024-01-02 | Garratt John W | Director | A-Award | A | Humana Common | 430 | 0.00 | — | 1,685 | — | ↗ |
| 2024-01-02 | Frederick Wayne A.I. | Director | A-Award | A | Restricted Stock Units | 430 | 0.00 | — | 430 | — | ↗ |
| 2024-01-02 | Feinberg David T | Director | A-Award | A | Restricted Stock Units | 430 | 0.00 | — | 430 | — | ↗ |
| 2024-01-02 | DAMELIO FRANK A | Director | A-Award | A | Restricted Stock Units | 430 | 0.00 | — | 430 | — | ↗ |
| 2024-01-02 | Bono Raquel C. | Director | A-Award | A | Restricted Stock Units | 430 | 0.00 | — | 430 | — | ↗ |
| 2023-12-31 | SMITH BRAD D | Director | A-Award | A | Restricted Stock Units | 3 | 0.00 | — | 3 | — | ↗ |
| 2023-12-31 | McDonald William J. | Director | A-Award | A | Restricted Stock Units | 257 | 0.00 | — | 2,123 | — | ↗ |
| 2023-12-31 | Klevorn Marcy S | Director | A-Award | A | Restricted Stock Units | 6 | 0.00 | — | 8 | — | ↗ |
| 2023-12-31 | KATZ KAREN | Director | A-Award | A | Restricted Stock Units | 17 | 0.00 | — | 37 | — | ↗ |
| 2023-12-31 | HILZINGER KURT J | Director | A-Award | A | Restricted Stock Units | 304 | 0.00 | — | 2,188 | — | ↗ |
| 2023-12-31 | Garratt John W | Director | A-Award | A | Restricted Stock Units | 2 | 0.00 | — | 2 | — | ↗ |
| 2023-12-31 | Frederick Wayne A.I. | Director | A-Award | A | Restricted Stock Units | 9 | 0.00 | — | 15 | — | ↗ |
| 2023-12-31 | Feinberg David T | Director | A-Award | A | Restricted Stock Units | 3 | 0.00 | — | 3 | — | ↗ |
| 2023-12-31 | Bono Raquel C. | Director | A-Award | A | Restricted Stock Units | 9 | 0.00 | — | 15 | — | ↗ |
| 2023-12-15 | Ventura Joseph C | Officer | M-Exempt | A | Humana Common | 359 | 0.00 | — | 4,938 | — | ↗ |
| 2023-12-15 | Shetty Sanjay K | Officer | F-InKind | D | Humana Common | 139 | 463.58 | 64.4K | 169 | — | ↗ |
| 2023-12-15 | Renaudin George II | Officer | M-Exempt | A | Humana Common | 229 | 0.00 | — | 1,421 | — | ↗ |
| 2023-12-15 | Huval Timothy S. | Officer | M-Exempt | A | Humana Common | 343 | 0.00 | — | 5,122 | — | ↗ |
| 2023-12-15 | Fleming William Kevin | Officer | M-Exempt | A | Humana Common | 345 | 0.00 | — | 7,974 | — | ↗ |
| 2023-12-15 | Felter John-Paul W. | Officer | F-InKind | D | Humana Common | 36 | 463.58 | 16.7K | 223 | — | ↗ |
| 2023-12-15 | Diamond Susan M | Officer | F-InKind | D | Humana Common | 171 | 463.58 | 79.3K | 3,493 | — | ↗ |
| 2023-12-15 | Deshpande Samir | Officer | M-Exempt | A | Humana Common | 334 | 0.00 | — | 10,079 | — | ↗ |
| 2023-12-15 | BROUSSARD BRUCE D | Director / Officer | M-Exempt | D | Restricted Stock Units | 2,184 | 0.00 | — | 2,184 | — | ↗ |
| 2023-12-15 | Agrawal Vishal | Officer | M-Exempt | A | Humana Common | 309 | 0.00 | — | 8,805 | — | ↗ |
| 2023-11-06 | Huval Timothy S. | Officer | G-Gift | D | Humana Common | 600 | 0.00 | — | 4,368 | — | ↗ |
| 2023-09-29 | SMITH BRAD D | Director | A-Award | A | Restricted Stock Units | 59 | 0.00 | — | 191 | — | ↗ |
| 2023-09-29 | HILZINGER KURT J | Director | A-Award | A | Restricted Stock Units | 181 | 0.00 | — | 12,605 | — | ↗ |
| 2023-09-29 | Feinberg David T | Director | A-Award | A | Restricted Stock Units | 33 | 0.00 | — | 101 | — | ↗ |
| 2023-09-15 | SMITH BRAD D | Director | M-Exempt | A | Humana Common | 386 | 0.00 | — | 386 | — | ↗ |
| 2023-08-01 | Felter John-Paul W. | Officer | M-Exempt | D | Restricted Stock Units | 210 | 0.00 | — | 421 | — | ↗ |
| 2023-08-01 | Diamond Susan M | Officer | F-InKind | D | Humana Common | 145 | 458.14 | 66.4K | 3,297 | — | ↗ |
| 2023-06-30 | SMITH BRAD D | Director | A-Award | A | Restricted Stock Units | 70 | 0.00 | — | 132 | — | ↗ |
| 2023-06-30 | HILZINGER KURT J | Director | A-Award | A | Restricted Stock Units | 215 | 0.00 | — | 12,424 | — | ↗ |
| 2023-06-30 | Feinberg David T | Director | A-Award | A | Restricted Stock Units | 37 | 0.00 | — | 68 | — | ↗ |
| 2023-05-05 | Diamond Susan M | Officer | J-Other | D | Humana Common | 700 | 0.00 | — | 3,131 | — | ↗ |
| 2023-05-04 | Diamond Susan M | Officer | M-Exempt | A | Humana Common | 1,508 | 376.61 | 567.9K | 6,226 | — | ↗ |
| 2023-04-20 | OBRIEN JAMES J /KY | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-04-20 | JONES DAVID A JR/KY | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-04-01 | Shetty Sanjay K | Officer | A-Award | A | Options | 3,964 | 487.16 | 1.93M | 3,964 | — | ↗ |
| 2023-04-01 | Schick Susan D. | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-04-01 | Agwunobi, M.D. Andrew C. | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-03-31 | SMITH BRAD D | Director | A-Award | A | Restricted Stock Units | 62 | 0.00 | — | 62 | — | ↗ |
| 2023-03-31 | HILZINGER KURT J | Director | A-Award | A | Restricted Stock Units | 194 | 0.00 | — | 12,209 | — | ↗ |
| 2023-03-31 | Feinberg David T | Director | A-Award | A | Restricted Stock Units | 31 | 0.00 | — | 31 | — | ↗ |
| 2023-03-27 | Shetty Sanjay K | Officer | — | D | Humana Common | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-03-01 | Feinberg David T | Director | M-Exempt | A | Humana Common | 441 | 0.00 | — | 441 | — | ↗ |
Executive team
Executive compensation
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Celeste M. Mellet Chief Financial Officer | 900.0K | 6.00M | 10.65M | — | 1.33M | 43.9K | 18.92M | 56.29% | ↗ |
| 2 | 2025 | James A. Rechtin President and Chief Executive Officer | 1.35M | — | 13.87M | — | 3.03M | 505.6K | 18.76M | 73.94% | ↗ |
| 3 | 2025 | Japan A. Mehta Chief Information Officer | 618.8K | 4.30M | 3.91M | — | 732.8K | 4.1K | 9.56M | 40.87% | ↗ |
| 4 | 2025 | Michelle A. O’Hara Chief Human Resources Officer | 715.4K | 2.50M | 4.86M | — | 840.0K | 24.1K | 8.94M | 54.38% | ↗ |
| 5 | 2025 | Sanjay K. Shetty, M.D. President, CenterWell | 715.8K | 250.0K | 5.06M | — | 963.3K | 163.5K | 7.16M | 70.76% | ↗ |
| 6 | 2025 | Susan M. Diamond Former Chief Financial Officer | 961.1K | — | — | — | 1.23M | 196.9K | 2.38M | 0.00% | ↗ |
| 7 | 2024 | David E. Dintenfass President, Enterprise Growth | 605.8K | 5.68M | 6.08M | 4.88M | 601.4K | 208.2K | 18.06M | 60.69% | ↗ |
| 8 | 2024 | James A. Rechtin President and Chief Executive Officer | 1.11M | — | 7.32M | 4.50M | 1.94M | 716.8K | 15.58M | 75.83% | ↗ |
| 9 | 2024 | James A. Rechtin Chief Executive Officer | 1.11M | — | 7.32M | 4.50M | 1.94M | 716.8K | 15.58M | 75.83% | ↗ |
| 10 | 2024 | Bruce D. Broussard Former Chief Executive Officer | 1.34M | — | 8.00M | — | 2.49M | 221.1K | 12.06M | 66.35% | ↗ |
| 11 | 2024 | Susan M. Diamond Chief Financial Officer | 846.2K | — | 6.73M | 948.1K | 911.4K | 178.0K | 9.62M | 79.87% | ↗ |
| 12 | 2024 | Susan M. Diamond Former Chief Financial Officer | 846.2K | — | 6.73M | 948.1K | 911.4K | 178.0K | 9.62M | 79.87% | ↗ |
| 13 | 2024 | Sanjay K. Shetty, M.D. President, CenterWell | 694.8K | 550.0K | 3.80M | 623.8K | 661.1K | 107.2K | 6.44M | 68.72% | ↗ |
| 14 | 2024 | Sanjay K. Shetty, M.D. President, CenterWell | 694.8K | 550.0K | 3.80M | 623.8K | 661.1K | 107.2K | 6.44M | 68.72% | ↗ |
| 15 | 2024 | George Renaudin II President, Insurance | 717.9K | — | 3.91M | 661.2K | 756.6K | 110.0K | 6.15M | 74.24% | ↗ |
| 16 | 2023 | Bruce D. Broussard, Chief Executive Officer | 1.47M | — | 10.90M | 3.49M | — | 465.8K | 16.33M | 88.14% | ↗ |
| 17 | 2023 | Bruce D. Broussard Former Chief Executive Officer | 1.47M | — | 10.90M | 3.49M | — | 465.8K | 16.33M | 88.14% | ↗ |
| 18 | 2023 | Susan M. Diamond Chief Financial Officer | 790.0K | — | 2.80M | 898.1K | — | 239.8K | 4.73M | 78.23% | ↗ |
| 19 | 2023 | Susan M. Diamond, Chief Financial Officer | 790.0K | — | 2.80M | 898.1K | — | 239.8K | 4.73M | 78.23% | ↗ |
| 20 | 2023 | Susan M. Diamond Former Chief Financial Officer | 790.0K | — | 2.80M | 898.1K | — | 239.8K | 4.73M | 78.23% | ↗ |
| 21 | 2023 | Sanjay K. Shetty, M.D., President, CenterWell | 493.3K | 1.40M | 1.40M | 449.8K | — | 837.8K | 4.58M | 40.40% | ↗ |
| 22 | 2023 | Sanjay K. Shetty, M.D. President, CenterWell | 493.3K | 1.40M | 1.40M | 449.8K | — | 837.8K | 4.58M | 40.40% | ↗ |
| 23 | 2023 | Sanjay K. Shetty, M.D. President, CenterWell | 493.3K | 1.40M | 1.40M | 449.8K | — | 837.8K | 4.58M | 40.40% | ↗ |
| 24 | 2023 | Joseph C. Ventura, Chief Legal Officer | 678.0K | — | 1.71M | 548.9K | — | 162.4K | 3.10M | 72.91% | ↗ |
| 25 | 2023 | George Renaudin II, President, Medicare Medicaid | 655.0K | — | 1.71M | 548.9K | — | 135.7K | 3.05M | 74.10% | ↗ |
| 26 | 2023 | George Renaudin II President, Insurance | 655.0K | — | 1.71M | 548.9K | — | 135.7K | 3.05M | 74.10% | ↗ |
| 27 | 2022 | Bruce D. Broussard Former Chief Executive Officer | 1.35M | — | 9.64M | 2.79M | 3.07M | 353.0K | 17.20M | 72.24% | ↗ |
| 28 | 2022 | Bruce D. Broussard, President and Chief Executive Officer | 1.35M | — | 9.64M | 2.79M | 3.07M | 353.0K | 17.20M | 72.24% | ↗ |
| 29 | 2022 | Bruce D. Broussard, Chief Executive Officer | 1.35M | — | 9.64M | 2.79M | 3.07M | 353.0K | 17.20M | 72.24% | ↗ |
| 30 | 2022 | Susan M. Diamond, Chief Financial Officer | 750.0K | — | 2.26M | 652.8K | 975.8K | 174.2K | 4.81M | 60.51% | ↗ |
| 31 | 2022 | Susan M. Diamond Chief Financial Officer | 750.0K | — | 2.26M | 652.8K | 975.8K | 174.2K | 4.81M | 60.51% | ↗ |
| 32 | 2022 | T. Alan Wheatley, Segment President, Retail | 665.0K | — | 2.18M | 630.2K | 865.2K | 131.2K | 4.47M | 62.85% | ↗ |
| 33 | 2022 | Timothy S. Huval, Chief Administrative Officer | 663.0K | — | 1.60M | 461.5K | 862.6K | 150.6K | 3.73M | 55.12% | ↗ |
| 34 | 2022 | Joseph C. Ventura, Chief Legal Officer | 600.6K | — | 1.60M | 461.5K | 784.1K | 155.7K | 3.60M | 57.20% | ↗ |
| 35 | 2021 | Bruce D. Broussard, Chief Executive Officer | 1.35M | — | 9.83M | 2.78M | 2.13M | 444.6K | 16.53M | 76.29% | ↗ |
| 36 | 2021 | Bruce D. Broussard, President and Chief Executive Officer | 1.35M | — | 9.83M | 2.78M | 2.13M | 444.6K | 16.53M | 76.30% | ↗ |
| 37 | 2021 | Brian A. Kane, Former Chief Financial Officer | 762.1K | — | 3.06M | 864.9K | 685.9K | 191.2K | 5.56M | 70.53% | ↗ |
| 38 | 2021 | T. Alan Wheatley, Segment President, Retail | 657.3K | — | 2.19M | 620.0K | 591.6K | 161.1K | 4.22M | 66.61% | ↗ |
| 39 | 2021 | Susan M. Diamond, Chief Financial Officer | 641.0K | — | 1.86M | 814.0K | 576.9K | 168.5K | 4.06M | 65.87% | ↗ |
| 40 | 2021 | Susan M. Diamond Chief Financial Officer | 641.0K | — | 1.86M | 814.0K | 576.9K | 168.5K | 4.06M | 65.87% | ↗ |
| 41 | 2021 | Timothy S. Huval, Chief Administrative Officer | 660.5K | — | 1.62M | 457.1K | 594.5K | 173.6K | 3.50M | 59.21% | ↗ |
| 42 | 2021 | William K. Fleming, PharmD Segment President , Pharmacy Solutions Chief Corporate Affairs Officer | 558.1K | — | 1.55M | 439.2K | 502.3K | 155.1K | 3.21M | 62.11% | ↗ |
| 43 | 2020 | Bruce D. Broussard, President and Chief Executive Officer | 1.35M | — | 8.51M | 2.81M | 3.29M | 527.8K | 16.49M | 68.65% | ↗ |
| 44 | 2020 | Brian A. Kane, Chief Financial Officer | 750.0K | — | 2.65M | 874.1K | 1.05M | 226.2K | 5.54M | 63.53% | ↗ |
| 45 | 2020 | Brian A. Kane, Former Chief Financial Officer | 750.0K | — | 2.65M | 874.1K | 1.05M | 226.2K | 5.54M | 63.53% | ↗ |
| 46 | 2020 | T. Alan Wheatley, Segment President, Retail | 625.0K | — | 1.82M | 599.4K | 871.3K | 169.1K | 4.08M | 59.19% | ↗ |
| 47 | 2020 | Timothy S. Huval, Chief Administrative Officer | 650.0K | — | 1.29M | 424.5K | 906.1K | 205.6K | 3.47M | 49.27% | ↗ |
| 48 | 2020 | William K. Fleming, PharmD Segment President , Pharmacy Solutions Chief Corporate Affairs Officer | 550.0K | — | 1.36M | 449.5K | 766.7K | 185.9K | 3.31M | 54.66% | ↗ |
| 49 | 2020 | William K. Fleming, PharmD Segment President, Clinical and Pharmacy Solutions | 550.0K | — | 1.36M | 449.5K | 766.7K | 185.9K | 3.31M | 54.66% | ↗ |
| 50 | 2019 | Bruce D. Broussard, President and Chief Executive Officer | 1.34M | — | 8.48M | 2.81M | 3.61M | 485.8K | 16.73M | 67.52% | ↗ |
| 51 | 2019 | Brian A. Kane, Chief Financial Officer | 740.6K | — | 2.45M | 813.0K | 1.14M | 233.0K | 5.38M | 60.63% | ↗ |
| 52 | 2019 | Brian A. Kane, Former Chief Financial Officer | 740.6K | — | 2.45M | 813.0K | 1.14M | 233.0K | 5.38M | 60.63% | ↗ |
| 53 | 2019 | T. Alan Wheatley, Segment President, Retail | 596.7K | — | 1.66M | 542.6K | 922.5K | 121.5K | 3.84M | 57.29% | ↗ |
| 54 | 2019 | Timothy S. Huval, Chief Administrative Officer | 638.9K | — | 1.28M | 425.2K | 987.7K | 177.1K | 3.51M | 48.62% | ↗ |
| 55 | 2019 | William K. Fleming, PharmD Segment President, Clinical and Pharmacy Solutions | 535.9K | — | 1.51M | 493.3K | 828.4K | 130.9K | 3.50M | 57.23% | ↗ |
| 56 | 2019 | William K. Fleming, PharmD Segment President , Pharmacy Solutions Chief Corporate Affairs Officer | 535.9K | — | 1.51M | 493.3K | 828.4K | 130.9K | 3.50M | 57.23% | ↗ |
| 57 | 2018 | Bruce D. Broussard, President and Chief Executive Officer | 1.27M | — | 8.61M | 2.74M | 3.23M | 455.3K | 16.31M | 69.59% | ↗ |
| 58 | 2018 | Brian A. Kane, Chief Financial Officer | 700.0K | — | 2.35M | 747.4K | 1.02M | 193.4K | 5.01M | 61.86% | ↗ |
| 59 | 2018 | Timothy S. Huval, Chief Human Resources Officer | 590.9K | — | 1.29M | 411.1K | 857.4K | 162.5K | 3.31M | 51.39% | ↗ |
| 60 | 2018 | Timothy S. Huval, Chief Administrative Officer | 590.9K | — | 1.29M | 411.1K | 857.4K | 162.5K | 3.31M | 51.39% | ↗ |
| 61 | 2018 | Jody L. Bilney, Chief Consumer Officer | 590.9K | — | 1.21M | 386.2K | 857.4K | 157.1K | 3.20M | 49.91% | ↗ |
| 62 | 2018 | William K. Fleming, PharmD Segment President, Clinical and Pharmacy Solutions | 475.0K | — | 1.55M | 495.1K | 516.9K | 120.9K | 3.16M | 64.75% | ↗ |
| 63 | 2018 | William K. Fleming, Segment President, Healthcare Services | 475.0K | — | 1.55M | 495.1K | 516.9K | 120.9K | 3.16M | 64.75% | ↗ |
| 64 | 2017 | Bruce D. Broussard, President and Chief Executive Officer | 1.27M | — | 10.20M | 5.28M | 2.67M | 348.1K | 19.77M | 78.29% | ↗ |
| 65 | 2017 | Brian A. Kane, Chief Financial Officer | 698.8K | — | 2.37M | 1.49M | 978.3K | 120.3K | 5.66M | 68.24% | ↗ |
| 66 | 2017 | Jody L. Bilney, Chief Consumer Officer | 590.6K | — | 2.03M | 1.16M | 826.8K | 138.7K | 4.74M | 67.20% | ↗ |
| 67 | 2017 | Timothy S. Huval, Chief Administrative Officer | 590.6K | — | 2.03M | 1.16M | 826.8K | 134.8K | 4.74M | 67.25% | ↗ |
| 68 | 2017 | Timothy S. Huval, Chief Human Resources Officer | 590.6K | — | 2.03M | 1.16M | 826.8K | 134.8K | 4.74M | 67.25% | ↗ |
| 69 | 2017 | Christopher M. Todoroff, Chief Legal Officer | 590.6K | — | 2.03M | 1.16M | 826.8K | 99.3K | 4.70M | 67.76% | ↗ |
| 70 | 2016 | Bruce D. Broussard, President and Chief Executive Officer | 1.24M | — | 11.89M | 4.37M | 1.97M | 254.0K | 19.72M | 82.44% | ↗ |
| 71 | 2016 | James E. Murray , Executive Vice President Chief Operating Officer | 835.5K | — | 3.65M | 1.20M | 889.8K | 149.7K | 6.72M | 72.11% | ↗ |
| 72 | 2016 | Brian A. Kane, Chief Financial Officer | 636.3K | — | 2.59M | 774.3K | 677.6K | 106.6K | 4.78M | 70.31% | ↗ |
| 73 | 2016 | Brian A. Kane, Senior Vice President Chief Financial Officer | 636.3K | — | 2.59M | 774.3K | 677.6K | 106.6K | 4.78M | 70.31% | ↗ |
| 74 | 2016 | Jody Bilney, Senior Vice President Chief Consumer Officer | 573.5K | — | 2.28M | 774.3K | 610.7K | 101.2K | 4.34M | 70.36% | ↗ |
| 75 | 2016 | Jody L. Bilney, Chief Consumer Officer | 573.5K | — | 2.28M | 774.3K | 610.7K | 101.2K | 4.34M | 70.36% | ↗ |
| 76 | 2016 | Timothy S. Huval , Senior Vice President Chief Human Resources Officer | 573.5K | — | 2.28M | 774.3K | 610.7K | 87.7K | 4.32M | 70.58% | ↗ |
| 77 | 2016 | Timothy S. Huval, Chief Human Resources Officer | 573.5K | — | 2.28M | 774.3K | 610.7K | 87.7K | 4.32M | 70.58% | ↗ |
| 78 | 2015 | Bruce D. Broussard, President and Chief Executive Officer | 1.24M | — | 4.37M | 4.39M | — | 331.8K | 10.34M | 84.77% | ↗ |
| 79 | 2015 | James E. Murray , Executive Vice President Chief Operating Officer | 842.1K | — | 1.20M | 1.20M | — | 201.0K | 3.45M | 69.74% | ↗ |
| 80 | 2015 | James E. Murray, Executive Vice President Chief Operating Officer | 842.1K | — | 1.20M | 1.20M | — | 201.0K | 3.45M | 69.74% | ↗ |
| 81 | 2015 | Brian A. Kane, Senior Vice President Chief Financial Officer | 641.1K | — | 775.0K | 777.7K | — | 126.5K | 2.32M | 66.92% | ↗ |
| 82 | 2015 | Brian A. Kane, Chief Financial Officer | 641.1K | — | 775.0K | 777.7K | — | 126.5K | 2.32M | 66.92% | ↗ |
| 83 | 2015 | Jody L. Bilney, Chief Consumer Officer | 577.8K | — | 775.0K | 777.7K | — | 128.7K | 2.26M | 68.73% | ↗ |
| 84 | 2015 | Jody Bilney, Senior Vice President Chief Consumer Officer | 577.8K | — | 775.0K | 777.7K | — | 128.7K | 2.26M | 68.73% | ↗ |
| 85 | 2015 | Timothy S. Huval, Senior Vice President Chief Human Resources Officer | 578.1K | — | 775.0K | 777.7K | — | 126.5K | 2.26M | 68.78% | ↗ |
| 86 | 2015 | Timothy S. Huval , Senior Vice President Chief Human Resources Officer | 578.1K | — | 775.0K | 777.7K | — | 126.5K | 2.26M | 68.78% | ↗ |
| 87 | 2015 | Timothy S. Huval, Chief Human Resources Officer | 578.1K | — | 775.0K | 777.7K | — | 126.5K | 2.26M | 68.78% | ↗ |
| 88 | 2014 | Bruce D. Broussard, President and Chief Executive Officer | 1.12M | — | 5.06M | 1.69M | 1.69M | 595.0K | 10.16M | 66.49% | ↗ |
| 89 | 2014 | Brian A. Kane, Senior Vice President Chief Financial Officer | 323.1K | 500.0K | 3.00M | — | 325.2K | 115.1K | 4.26M | 70.37% | ↗ |
| 90 | 2014 | Christopher H. Hunter, Senior Vice President Chief Strategy Officer | 465.9K | 600.0K | 2.25M | 236.0K | 469.0K | 137.0K | 4.16M | 59.79% | ↗ |
| 91 | 2014 | James E. Murray , Executive Vice President Chief Operating Officer | 786.2K | — | 1.65M | 550.6K | 786.2K | 244.2K | 4.02M | 54.78% | ↗ |
| 92 | 2014 | James E. Murray, Executive Vice President Chief Operating Officer | 786.2K | — | 1.65M | 550.6K | 786.2K | 244.2K | 4.02M | 54.78% | ↗ |
| 93 | 2014 | Timothy S. Huval, Senior Vice President Chief Human Resources Officer | 540.8K | 400.0K | 1.01M | 337.9K | 544.4K | 175.0K | 3.01M | 44.86% | ↗ |
| 94 | 2014 | Timothy S. Huval , Senior Vice President Chief Human Resources Officer | 540.8K | 400.0K | 1.01M | 337.9K | 544.4K | 175.0K | 3.01M | 44.86% | ↗ |
| 95 | 2014 | Jody Bilney, Senior Vice President Chief Consumer Officer | 539.5K | — | 1.01M | 337.9K | 543.1K | 120.9K | 2.55M | 52.88% | ↗ |
| 96 | 2014 | Steven E. McCulley, Senior Vice President Interim Chief Financial Officer | 378.5K | — | 1.10M | 200.2K | 285.8K | 83.6K | 2.05M | 63.48% | ↗ |
| 97 | 2013 | Bruce D. Broussard, President and Chief Executive Officer | 1.08M | — | 3.75M | 1.24M | 2.16M | 628.9K | 8.85M | 56.35% | ↗ |
| 98 | 2013 | Timothy S. Huval, Senior Vice President Chief Human Resources Officer | 504.8K | 400.0K | 2.51M | 333.6K | 757.2K | 358.7K | 4.87M | 58.48% | ↗ |
| 99 | 2013 | James E. Murray, Executive Vice President Chief Operating Officer | 764.4K | — | 1.50M | 494.2K | 1.15M | 203.5K | 4.11M | 48.54% | ↗ |
| 100 | 2013 | James H. Bloem, Senior Vice President Chief Financial Officer Treasurer | 637.0K | — | 1.31M | 432.4K | 955.5K | 128.0K | 3.47M | 50.35% | ↗ |
| 101 | 2013 | Jody L. Bilney, Senior Vice President Chief Consumer Officer | 353.4K | 300.0K | 1.12M | 364.8K | 530.0K | 378.7K | 3.05M | 48.82% | ↗ |
| 102 | 2013 | Jody Bilney, Senior Vice President Chief Consumer Officer | 353.4K | 300.0K | 1.12M | 364.8K | 530.0K | 378.7K | 3.05M | 48.82% | ↗ |
| 103 | 2012 | Michael B. McCallister, Chairman of the Board | 1.09M | — | 1.75M | 3.31M | 1.63M | 667.0K | 8.43M | 59.93% | ↗ |
| 104 | 2012 | James E. Murray, Executive Vice President Chief Operating Officer | 750.0K | — | 838.4K | 1.59M | 725.0K | 246.3K | 4.15M | 58.50% | ↗ |
| 105 | 2012 | Bruce D. Broussard, President and Chief Executive Officer | 900.0K | — | — | — | 1.35M | 631.2K | 2.88M | 0.00% | ↗ |
| 106 | 2012 | James H. Bloem, Senior Vice President Chief Financial Officer Treasurer | 625.0K | — | 489.1K | 926.2K | 625.0K | 141.2K | 2.81M | 50.43% | ↗ |
| 107 | 2012 | Paul B.K. Kusserow, Senior Vice President and Chief Strategy and Development Officer | 500.0K | — | 419.2K | 793.9K | 500.0K | 156.6K | 2.37M | 51.19% | ↗ |
| 108 | 2012 | Jody L. Bilney, Senior Vice President Chief Consumer Officer | — | — | — | — | — | — | — | — | ↗ |
| 109 | 2012 | Timothy S. Huval, Senior Vice President Chief Human Resources Officer | — | — | — | — | — | — | — | — | ↗ |
| 110 | 2011 | Bruce D. Broussard, President | 41.5K | — | 7.00M | 3.49M | — | 2.2K | 10.53M | 99.58% | ↗ |
| 111 | 2011 | Bruce D. Broussard, President and Chief Executive Officer | 41.5K | — | 7.00M | 3.49M | — | 2.2K | 10.53M | 99.58% | ↗ |
| 112 | 2011 | Michael B. McCallister, Chairman Chief Executive Officer | 1.06M | — | 1.28M | 2.31M | 2.11M | 546.5K | 7.31M | 49.13% | ↗ |
| 113 | 2011 | Michael B. McCallister, Chairman of the Board | 1.06M | — | 1.28M | 2.31M | 2.11M | 546.5K | 7.31M | 49.13% | ↗ |
| 114 | 2011 | James E. Murray, Executive Vice President Chief Operating Officer | 702.5K | — | 3.06M | 1.02M | 1.05M | 211.4K | 6.05M | 67.49% | ↗ |
| 115 | 2011 | James H. Bloem, Senior Vice President Chief Financial Officer Treasurer | 573.3K | — | 1.83M | 594.7K | 859.9K | 138.5K | 3.99M | 60.63% | ↗ |
| 116 | 2011 | V. Rajamannar Madabhushi, Senior Vice President Chief Innovation and Marketing Officer | 559.4K | — | 328.4K | 594.7K | 839.1K | 225.4K | 2.55M | 36.24% | ↗ |
| 117 | 2011 | Paul B.K. Kusserow, Senior Vice President and Chief Strategy and Development Officer | 484.7K | — | 328.4K | 637.4K | 727.1K | 163.8K | 2.34M | 41.25% | ↗ |
| 118 | 2011 | Jody L. Bilney, Senior Vice President Chief Consumer Officer | — | — | — | — | — | — | — | — | ↗ |
| 119 | 2011 | Timothy S. Huval, Senior Vice President Chief Human Resources Officer | — | — | — | — | — | — | — | — | ↗ |
| 120 | 2010 | Michael B. McCallister, Chairman Chief Executive Officer | 1.03M | — | — | 2.50M | 2.05M | 569.3K | 6.15M | 40.67% | ↗ |
| 121 | 2010 | Michael B. McCallister, Chairman of the Board | 1.03M | — | — | 2.50M | 2.05M | 569.3K | 6.15M | 40.67% | ↗ |
| 122 | 2010 | James E. Murray, Chief Operating Officer | 676.1K | — | — | 1.10M | 1.01M | 212.9K | 3.00M | 36.63% | ↗ |
| 123 | 2010 | James E. Murray, Executive Vice President Chief Operating Officer | 676.1K | — | — | 1.10M | 1.01M | 212.9K | 3.00M | 36.63% | ↗ |
| 124 | 2010 | V. Rajamannar Madabhushi, Senior Vice President Chief Innovation and Marketing Officer | 516.6K | — | — | 900.0K | 774.9K | 147.8K | 2.34M | 38.47% | ↗ |
| 125 | 2010 | James H. Bloem, Senior Vice President Chief Financial Officer Treasurer | 550.1K | — | — | 700.0K | 825.1K | 170.4K | 2.25M | 31.17% | ↗ |
| 126 | 2010 | Bonita C. Hathcock, Senior Vice President Chief Human Resources Officer | 480.0K | — | — | 700.0K | 720.0K | 164.0K | 2.06M | 33.92% | ↗ |
| 127 | 2010 | Paul B.K. Kusserow, Senior Vice President and Chief Strategy and Development Officer | 470.0K | — | — | 700.0K | 704.9K | 88.2K | 1.96M | 35.66% | ↗ |
| 128 | 2010 | Bruce D. Broussard, President | — | — | — | — | — | — | — | — | ↗ |
| 129 | 2010 | Bruce D. Broussard, President and Chief Executive Officer | — | — | — | — | — | — | — | — | ↗ |
| 130 | 2009 | Michael B. McCallister, President Chief Executive Officer | 1.03M | — | — | 3.39M | 1.79M | 297.2K | 6.51M | 52.13% | ↗ |
| 131 | 2009 | Michael B. McCallister, Chairman Chief Executive Officer | 1.03M | — | — | 3.39M | 1.79M | 297.2K | 6.51M | 52.13% | ↗ |
| 132 | 2009 | Paul B. Kusserow, Senior Vice President Chief Strategy Officer | 406.4K | — | 416.6K | 2.07M | 508.0K | 117.2K | 3.52M | 70.69% | ↗ |
| 133 | 2009 | James E. Murray, Executive Vice President Chief Operating Officer | 670.0K | — | — | 1.50M | 837.5K | 125.5K | 3.14M | 47.92% | ↗ |
| 134 | 2009 | James E. Murray, Chief Operating Officer | 670.0K | — | — | 1.50M | 837.5K | 125.5K | 3.14M | 47.92% | ↗ |
| 135 | 2009 | V. Rajamannar Madabhushi, Senior Vice President Chief Innovation and Marketing Officer | 342.5K | 218.7K | 587.3K | 1.14M | 428.1K | 95.2K | 2.81M | 61.39% | ↗ |
| 136 | 2009 | James H. Bloem, Senior Vice President Chief Financial Officer Treasurer | 545.0K | — | — | 1.02M | 681.3K | 81.7K | 2.33M | 43.77% | ↗ |
| 137 | 2009 | Bonita C. Hathcock, Senior Vice President Chief Human Resources Officer | 475.0K | — | — | 872.6K | — | 97.7K | 1.45M | 60.37% | ↗ |
| 138 | 2009 | Bruce D. Broussard, President | — | — | — | — | — | — | — | — | ↗ |
| 139 | 2008 | Michael B. McCallister, President Chief Executive Officer | 1.02M | — | — | 3.50M | — | 668.1K | 5.19M | 67.50% | ↗ |
| 140 | 2008 | Michael B. McCallister, Chairman Chief Executive Officer | 1.02M | — | — | 3.50M | — | 668.1K | 5.19M | 67.50% | ↗ |
| 141 | 2008 | James E. Murray, Chief Operating Officer | 663.8K | — | — | 1.55M | — | 245.1K | 2.46M | 63.04% | ↗ |
| 142 | 2008 | Bonita C. Hathcock, Senior Vice President Chief Human Resources Officer | 471.2K | — | — | 900.0K | 675.0K | 174.9K | 2.22M | 40.52% | ↗ |
| 143 | 2008 | James H. Bloem, Senior Vice President Chief Financial Officer Treasurer | 539.7K | — | — | 1.05M | — | 169.6K | 1.76M | 59.68% | ↗ |
| 144 | 2008 | Jonathan T. Lord, M.D. Senior Vice President Chief Innovation Officer | 517.2K | — | — | 892.4K | — | 179.0K | 1.59M | 56.18% | ↗ |
| 145 | 2008 | Bruce J. Goodman, Senior Vice President Chief Service Information Officer | 489.4K | — | — | 894.4K | — | 204.3K | 1.59M | 56.32% | ↗ |
| 146 | 2008 | Paul B. Kusserow, Senior Vice President Chief Strategy Officer | — | — | — | — | — | — | — | — | ↗ |
| 147 | 2008 | V. Rajamannar Madabhushi, Senior Vice President Chief Innovation and Marketing Officer | — | — | — | — | — | — | — | — | ↗ |
| 148 | 2007 | Michael B. McCallister, President Chief Executive Officer | 973.6K | — | — | 3.00M | 1.95M | 511.3K | 10.87M | 27.59% | ↗ |
| 149 | 2007 | James E. Murray, Chief Operating Officer | 629.4K | — | — | 1.55M | 945.0K | 220.3K | 4.64M | 33.41% | ↗ |
| 150 | 2007 | James H. Bloem, Senior Vice President Chief Financial Officer Treasurer | 509.4K | — | — | 1.05M | 765.0K | 147.5K | 3.08M | 34.12% | ↗ |
| 151 | 2007 | Jonathan T. Lord, M.D. Senior Vice President Chief Innovation Officer | 501.7K | — | — | 745.5K | 753.0K | 165.2K | 2.75M | 27.10% | ↗ |
| 152 | 2007 | Bruce J. Goodman, Senior Vice President Chief Service Information Officer | 474.7K | — | — | 756.5K | 712.5K | 194.0K | 2.18M | 34.77% | ↗ |
| 153 | 2007 | V. Rajamannar Madabhushi, Senior Vice President Chief Innovation and Marketing Officer | — | — | — | — | — | — | — | — | ↗ |
| 154 | 2007 | Paul B. Kusserow, Senior Vice President Chief Strategy Officer | — | — | — | — | — | — | — | — | ↗ |
| 155 | 2006 | Michael B. McCallister, President Chief Executive Officer | 900.0K | — | — | 2.38M | 1.55M | 424.5K | 5.80M | 41.02% | ↗ |
| 156 | 2006 | James E. Murray, Chief Operating Officer | 591.4K | — | — | 1.14M | 849.9K | 193.4K | 2.78M | 41.17% | ↗ |
| 157 | 2006 | Bruce J. Goodman, Senior Vice President Chief Service Information Officer | 460.0K | — | — | 767.0K | 660.9K | 165.7K | 2.20M | 34.91% | ↗ |
| 158 | 2006 | James H. Bloem, Senior Vice President Chief Financial Officer Treasurer | 470.0K | — | — | 829.1K | 675.2K | 126.3K | 2.10M | 39.42% | ↗ |
| 159 | 2006 | Jonathan T. Lord, M.D. Senior Vice President Chief Innovation Officer | 485.0K | 24.3K | — | 743.0K | 672.5K | 161.9K | 2.09M | 35.61% | ↗ |
| 160 | 2005 | Michael B. McCallister President Chief Executive Officer | 858.6K | 1.34M | — | 250.0K | — | 268.7K | 2.47M | 10.12% | ↗ |
| 161 | 2005 | James E. Murray Chief Operating Officer | 518.4K | 582.8K | — | 110.0K | — | 407.4K | 1.51M | 7.29% | ↗ |
| 162 | 2005 | Bruce J. Goodman Sr. Vice President Chief Service Information Officer | 443.1K | 498.2K | — | 80.0K | — | 219.4K | 1.16M | 6.89% | ↗ |
| 163 | 2005 | Jonathan T. Lord, M.D. Sr. Vice President Chief Innovation Officer | 468.1K | 526.3K | — | 75.0K | — | 114.0K | 1.11M | 6.77% | ↗ |
| 164 | 2005 | James H. Bloem Sr. Vice President, Chief Financial Officer Treasurer | 443.3K | 498.4K | — | 80.0K | — | 92.3K | 1.03M | 7.74% | ↗ |
| 165 | 2004 | James H. Bloem Sr. Vice President, Chief Financial Officer Treasurer | 410.4K | 406.3K | — | 70.0K | — | 1.62M | 2.44M | 2.87% | ↗ |
| 166 | 2004 | Michael B. McCallister President Chief Executive Officer | 723.1K | 1.25M | — | 200.0K | — | 318.2K | 2.29M | 8.74% | ↗ |
| 167 | 2004 | James E. Murray Chief Operating Officer | 480.5K | 475.7K | — | 85.0K | — | 205.4K | 1.16M | 7.32% | ↗ |
| 168 | 2004 | Jonathan T. Lord, M.D. Sr. Vice President Chief Innovation Officer | 435.4K | 431.1K | — | 70.0K | — | 108.7K | 975.2K | 7.18% | ↗ |
| 169 | 2004 | Bruce J. Goodman Sr. Vice President Chief Service Information Officer | 410.4K | 406.3K | — | 70.0K | — | 133.2K | 949.9K | 7.37% | ↗ |
| 170 | 2003 | Michael B. McCallister President Chief Executive Officer | 713.9K | 1.07M | — | 200.0K | — | 3.92M | 5.70M | 3.51% | ↗ |
| 171 | 2003 | James E. Murray Chief Operating Officer | 476.6K | 572.0K | — | 50.0K | — | 2.60M | 3.65M | 1.37% | ↗ |
| 172 | 2003 | James E. Murray Chief Operating Officer—Market Business Segment Operations | 476.6K | 572.0K | — | 50.0K | — | 2.60M | 3.65M | 1.37% | ↗ |
| 173 | 2003 | Bruce J. Goodman Sr. Vice President Chief Service Information Officer | 406.6K | 366.0K | — | 50.0K | — | 2.52M | 3.29M | 1.52% | ↗ |
| 174 | 2003 | Jonathan T. Lord, M.D. Sr. Vice President Chief Innovation Officer | 431.6K | 440.3K | — | 50.0K | — | 1.69M | 2.57M | 1.95% | ↗ |
| 175 | 2003 | James H. Bloem Sr. Vice President, Chief Financial Officer Treasurer | 401.6K | 361.4K | — | 70.0K | — | 61.7K | 824.7K | 8.49% | ↗ |
| 176 | 2002 | Michael B. McCallister President Chief Executive Officer | 700.0K | 612.5K | — | 50.0K | — | 276.6K | 1.59M | 3.15% | ↗ |
| 177 | 2002 | James E. Murray Chief Operating Officer | 470.0K | 359.0K | — | 20.0K | — | 312.5K | 1.14M | 1.75% | ↗ |
| 178 | 2002 | James E. Murray Chief Operating Officer—Market Business Segment Operations | 470.0K | 359.0K | — | 20.0K | — | 312.5K | 1.14M | 1.75% | ↗ |
| 179 | 2002 | Jonathan T. Lord, M.D. Sr. Vice President Chief Innovation Officer | 425.0K | 280.0K | — | 30.0K | — | 42.4K | 747.3K | 4.01% | ↗ |
| 180 | 2002 | Bruce J. Goodman Sr. Vice President Chief Service Information Officer | 378.3K | 216.7K | — | 60.0K | — | 132.9K | 727.9K | 8.24% | ↗ |
| 181 | 2002 | James H. Bloem Sr. Vice President, Chief Financial Officer Treasurer | 385.0K | 220.6K | — | 30.0K | — | 19.3K | 624.9K | 4.80% | ↗ |
| 182 | 2002 | Michael B. McCallister President Chief Executive Officer Chief Operating Officer—Market Sr. Vice President Chief Innovation Chief Service Chief Financial | — | — | — | — | — | — | — | — | ↗ |
| 183 | 2001 | Michael B. McCallister President Chief Executive Officer | 655.9K | 819.9K | — | — | — | 102.7K | 1.58M | 0.00% | ↗ |
| 184 | 2001 | Michael B. McCallister President Chief Executive O fficer | 655.9K | 819.9K | — | — | — | 102.7K | 1.58M | 0.00% | ↗ |
| 185 | 2001 | James E. Murray Chief Operating Officer—Service | 470.0K | 470.0K | — | — | — | 87.9K | 1.03M | 0.00% | ↗ |
| 186 | 2001 | James E. Murray Chief Operating Officer—Market Business Segment Operations | 470.0K | 470.0K | — | — | — | 87.9K | 1.03M | 0.00% | ↗ |
| 187 | 2001 | Kenneth J. Fasola Chief Operating Officer—Market | 470.0K | 470.0K | — | — | — | 36.0K | 976.0K | 0.00% | ↗ |
| 188 | 2001 | Jonthan T. Lord, M.D. Sr. Vice President Chief Clinical | 425.0K | 361.3K | — | — | — | — | 786.3K | 0.00% | ↗ |
| 189 | 2001 | Jonathan T. Lord, M.D. Sr. Vice President Chief Innovation Officer | 425.0K | 361.3K | — | — | — | — | 786.3K | 0.00% | ↗ |
| 190 | 2001 | James H. Bloem Sr. Vice President Chief Financial | 332.4K | 249.3K | 75.0K | 75.0K | — | — | 656.6K | 22.84% | ↗ |
| 191 | 2001 | Bruce J. Goodman Sr. Vice President Chief Service Information Officer | 325.9K | 244.4K | — | — | — | 27.7K | 598.0K | 0.00% | ↗ |
| 192 | 2001 | James H. Bloem Sr. Vice President, Chief Financial Officer Treasurer | 332.4K | 249.3K | — | 75.0K | — | — | 581.6K | 12.89% | ↗ |
| 193 | 2001 | Michael B. McCallister President Chief Executive Officer Chief Operating Officer—Market Sr. Vice President Chief Innovation Chief Service Chief Financial | — | — | — | — | — | — | — | — | ↗ |
| 194 | 2000 | David A. Jones Chairman (Interim Chief | 1.11M | — | — | 5.0K | — | 720.1K | 1.83M | 0.27% | ↗ |
| 195 | 2000 | Michael B. McCallister President Chief Executive Officer | 624.6K | 390.4K | 225.0K | 500.0K | — | 76.2K | 1.32M | 55.08% | ↗ |
| 196 | 2000 | Michael B. McCallister President Chief Executive O fficer | 624.6K | 390.4K | 225.0K | 500.0K | — | 76.2K | 1.32M | 55.08% | ↗ |
| 197 | 2000 | Kenneth J. Fasola Chief Operating Officer—Market | 470.0K | 235.0K | 150.0K | — | — | 116.6K | 971.6K | 15.44% | ↗ |
| 198 | 2000 | James E. Murray Chief Operating Officer—Service | 469.6K | 235.0K | 150.0K | — | — | 58.9K | 913.5K | 16.42% | ↗ |
| 199 | 2000 | Bruce J. Goodman Senior Vice President Chief Information | 319.9K | 270.0K | 150.0K | — | — | 11.1K | 751.0K | 19.97% | ↗ |
| 200 | 2000 | Jonathan T. Lord, M.D. Senior Vice President Chief Clinical | 291.5K | 180.6K | 100.0K | 150.0K | — | 4.6K | 576.7K | 43.35% | ↗ |
| 201 | 2000 | Jonthan T. Lord, M.D. Sr. Vice President Chief Clinical | 291.5K | 180.6K | 100.0K | 150.0K | — | 4.6K | 576.7K | 43.35% | ↗ |
| 202 | 2000 | Michael B. McCallister President Chief Executive Officer Chief Operating Officer—Market Sr. Vice President Chief Innovation Chief Service Chief Financial | — | — | — | — | — | — | — | — | ↗ |
| 203 | 2000 | James H. Bloem Sr. Vice President Chief Financial | — | — | — | — | — | — | — | — | ↗ |
| 204 | 1999 | Gregory H. Wolf Former President Chief Executive | 500.7K | 500.7K | — | 200.0K | — | 2.68M | 3.68M | 5.43% | ↗ |
| 205 | 1999 | David A. Jones Chairman (Former Interim Chief | 205.0K | — | — | 5.0K | — | 720.1K | 925.1K | 0.54% | ↗ |
| 206 | 1999 | David A. Jones Chairman (Interim Chief | 205.0K | — | — | 5.0K | — | 720.1K | 925.1K | 0.54% | ↗ |
| 207 | 1999 | Kenneth J. Fasola Chief Operating Officer—Small Group | 432.6K | 235.0K | — | 130.0K | — | 74.0K | 741.6K | 17.53% | ↗ |
| 208 | 1999 | Kenneth J. Fasola Chief Operating Officer—Market | 432.6K | 235.0K | — | 130.0K | — | 74.0K | 741.6K | 17.53% | ↗ |
| 209 | 1999 | Michael B. McCallister President Chief Executive Officer | 350.0K | 250.0K | — | 130.0K | — | 97.6K | 697.6K | 18.64% | ↗ |
| 210 | 1999 | Michael B. McCallister President Chief Executive O fficer | 350.0K | 250.0K | — | 130.0K | — | 97.6K | 697.6K | 18.64% | ↗ |
| 211 | 1999 | James E. Murray Chief Operating Officer—Service | 320.0K | 175.0K | — | 130.0K | — | 78.6K | 573.6K | 22.66% | ↗ |
| 212 | 1999 | James E. Murray Chief Operating Officer—Health Plan | 320.0K | 175.0K | — | 130.0K | — | 78.6K | 573.6K | 22.66% | ↗ |
| 213 | 1999 | Jerry D. Reeves, M.D. Former Sr. Vice President and Chief | 320.0K | 45.6K | — | 50.0K | — | 52.7K | 418.3K | 11.95% | ↗ |
| 214 | 1999 | Bruce J. Goodman Senior Vice President Chief Information | 217.0K | 45.0K | 5.0K | 75.0K | — | — | 267.0K | 29.96% | ↗ |
| 215 | 1999 | Jonathan T. Lord, M.D. Senior Vice President Chief Clinical | — | — | — | — | — | — | — | — | ↗ |
| 216 | 1999 | Jonthan T. Lord, M.D. Sr. Vice President Chief Clinical | — | — | — | — | — | — | — | — | ↗ |
| 217 | 1999 | James H. Bloem Sr. Vice President Chief Financial | — | — | — | — | — | — | — | — | ↗ |
| 218 | 1998 | Gregory H. Wolf Former President Chief Executive | 800.0K | 697.6K | — | 434.7K | — | 122.7K | 1.62M | 26.83% | ↗ |
| 219 | 1998 | David A. Jones Chairman (Former Interim Chief | 205.0K | — | — | 5.0K | — | 840.1K | 1.05M | 0.48% | ↗ |
| 220 | 1998 | David A. Jones Chairman (Interim Chief | 205.0K | — | — | 5.0K | — | 840.1K | 1.05M | 0.48% | ↗ |
| 221 | 1998 | Michael B. McCallister President Chief Executive Officer | 350.0K | 228.9K | 12.0K | 152.9K | — | 62.3K | 653.2K | 25.24% | ↗ |
| 222 | 1998 | Jerry D. Reeves, M.D. Former Sr. Vice President and Chief | 320.0K | 209.3K | 10.0K | 166.2K | — | 11.3K | 550.5K | 32.01% | ↗ |
| 223 | 1998 | Kenneth J. Fasola Chief Operating Officer—Small Group | 284.8K | 186.2K | 15.0K | 249.4K | — | 48.6K | 534.6K | 49.47% | ↗ |
| 224 | 1998 | Kenneth J. Fasola Chief Operating Officer—Market | 284.8K | 186.2K | 15.0K | 249.4K | — | 48.6K | 534.6K | 49.47% | ↗ |
| 225 | 1998 | James E. Murray Chief Operating Officer—Service | 277.3K | 181.2K | 15.0K | 168.8K | — | 43.8K | 517.3K | 35.53% | ↗ |
| 226 | 1998 | James E. Murray Chief Operating Officer—Health Plan | 277.3K | 181.2K | 15.0K | 168.8K | — | 43.8K | 517.3K | 35.53% | ↗ |
| 227 | 1998 | Bruce J. Goodman Senior Vice President Chief Information | — | — | — | — | — | — | — | — | ↗ |
| 228 | 1998 | Jonathan T. Lord, M.D. Senior Vice President Chief Clinical | — | — | — | — | — | — | — | — | ↗ |
| 229 | 1997 | David A. Jones Chairman (Former Interim Chief | 1.01M | 2.50M | — | 170.0K | — | 897.9K | 4.41M | 3.85% | ↗ |
| 230 | 1997 | Gregory H. Wolf Former President Chief Executive | 571.2K | 200.0K | 100.0K | 384.0K | — | 114.1K | 985.3K | 49.12% | ↗ |
| 231 | 1997 | Kenneth J. Fasola Chief Operating Officer—Small Group | 260.0K | 145.0K | — | 80.0K | — | 52.5K | 457.5K | 17.49% | ↗ |
| 232 | 1997 | Jerry D. Reeves, M.D. Former Sr. Vice President and Chief | 265.6K | 180.0K | 6.0K | 100.0K | — | — | 451.6K | 23.47% | ↗ |
| 233 | 1997 | Michael B. McCallister President Chief Executive Officer | 280.4K | 100.0K | — | 60.0K | — | 47.8K | 428.2K | 14.01% | ↗ |
| 234 | 1997 | James E. Murray Chief Operating Officer—Health Plan | 225.0K | 100.0K | — | 65.0K | — | 27.6K | 352.6K | 18.43% | ↗ |
Proxy statements
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Celeste Mellet | Chief Financial Officer | 8M | female |
| David Dintenfass | President of Enterprise Growth | 7M | male |
| Japan Mehta | Chief Information Officer | 6M | male |
| James A. Rechtin | President, Chief Executive Officer & Director | 5M | male |
| Michelle O'Hara | Chief Human Resources Officer | 4M | female |
| Bruce Dale Broussard | Strategic Advisor | 4M | male |
| Sanjay K. Shetty | President of CenterWell | 2M | — |
| George Renaudin | President of Insurance | 2M | male |
| Joseph C. Ventura | Chief Legal Officer | 840.4K | male |
| John-Paul W. Felter | Senior Vice President, Chief Accounting Officer & Controller | — | male |
| Kathie Ann Mancini | Regional President of East Central Medicare operations | — | female |
| Lisa Stoner | Vice President of Investor Relations | — | female |
No Senate trading activity found for this company.
| Transaction Date | Disclosed | Representative | District | Owner | Type | Amount | Link |
|---|---|---|---|---|---|---|---|
| 2026-02-10 | 2026-03-13 | Julia Letlow | — | — | Sale | $1,001 - $15,000 | ↗ |
| 2025-11-12 | 2025-12-15 | Gilbert Cisneros | CA31 | — | Sale (Full) | $1,001 - $15,000 | ↗ |
| 2025-11-04 | 2025-12-10 | Michael McCaul | TX10 | Spouse | Sale | $15,001 - $50,000 | ↗ |
| 2025-09-25 | 2025-10-22 | Lisa McClain | MI09 | Spouse | Purchase | $1,001 - $15,000 | ↗ |
| 2025-08-08 | 2026-01-13 | Julia Letlow | LA05 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2025-08-05 | 2025-09-12 | Gilbert Cisneros | CA31 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2025-07-25 | 2025-08-08 | Ro Khanna | CA17 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2025-06-24 | 2025-08-13 | Lisa McClain | MI09 | Spouse | Purchase | $1,001 - $15,000 | ↗ |
| 2025-05-30 | 2025-06-06 | Gilbert Cisneros | CA31 | — | Sale (Full) | $1,001 - $15,000 | ↗ |
| 2025-05-30 | 2025-06-09 | Gilbert Cisneros | CA31 | — | Sale | $1,001 - $15,000 | ↗ |
| 2025-05-28 | 2025-06-12 | Michael McCaul | TX10 | Spouse | Purchase | $15,001 - $50,000 | ↗ |
| 2025-05-19 | 2025-06-12 | Michael McCaul | TX10 | Spouse | Purchase | $50,001 - $100,000 | ↗ |
| 2025-05-19 | 2025-06-12 | Michael McCaul | TX10 | Spouse | Purchase | $15,001 - $50,000 | ↗ |
| 2025-05-15 | 2025-06-10 | Rob Bresnahan | PA08 | — | Sale | $1,001 - $15,000 | ↗ |
| 2025-04-29 | 2025-05-07 | Gilbert Cisneros | CA31 | — | Sale | $1,001 - $15,000 | ↗ |
| 2025-04-10 | 2025-05-15 | Michael McCaul | TX10 | Spouse | Purchase | $100,001 - $250,000 | ↗ |
| 2025-02-26 | 2025-03-07 | Gilbert Cisneros | CA31 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2025-02-25 | 2025-03-28 | Rob Bresnahan | PA08 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2025-01-23 | 2025-02-14 | Michael McCaul | TX10 | Spouse | Purchase | $100,001 - $250,000 | ↗ |
| 2025-01-15 | 2025-02-14 | Michael McCaul | TX10 | Spouse | Purchase | $15,001 - $50,000 | ↗ |
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for HUM
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
